Skip Navigation
Skip to contents

Cancer Res Treat : Cancer Research and Treatment

OPEN ACCESS

Articles

Page Path
HOME > Cancer Res Treat > Volume 49(2); 2017 > Article
Special Article Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2014
Kyu-Won Jung, MS1,2, Young-Joo Won, PhD1,2,3,, Chang-Mo Oh, MD, PhD1,2, Hyun-Joo Kong, MS1,2, Duk Hyoung Lee, MD, PhD2,3, Kang Hyun Lee, MD, PhD1, The Community of Population-Based Regional Cancer Registries,*
Cancer Research and Treatment : Official Journal of Korean Cancer Association 2017;49(2):292-305.
DOI: https://doi.org/10.4143/crt.2017.118
Published online: March 9, 2017

1The Korea Central Cancer Registry, National Cancer Center, Goyang, Korea

2National Cancer Control Institute, National Cancer Center, Goyang, Korea

3Department of Cancer Control and Population Health, National Cancer Center Graduate School of Cancer Science and Policy, Goyang, Korea

Correspondence: Young-Joo Won, PhD The Korea Central Cancer Registry, National Cancer Center, 323 Ilsan-ro, Ilsandong-gu, Goyang 10408, Korea
Tel: 82-31-920-2015 Fax: 82-31-920-2179 E-mail: astra67@ncc.re.kr
*Chang-Hoon Kim (Busan Cancer Registry, Pusan National University Hospital), Cheol-In Yoo (Ulsan Caner Registry, Ulsan University Hospital), Heon Kim (Chungbuk Cancer Registry, Chungbuk National University Hospital), Hae-Sung Nam (Daejeon/Chungnam Cancer Registry, Chungnam National University and Hospital), Jung-Sik Huh (Jeju Cancer Registry, Jeju National University and Hospital), Jung-Ho Youm (Chonbuk Cancer Registry, Chonbuk National University Hospital), Moo-Kyung Oh (Kangwon Cancer Registry, Kangwon National University Hospital), Nam-Soo Hong (Deagu/Gyeongbuk Cancer Registry, Kyungpook National University Medical Center), Sun-Seog Kweon (Gwangju/Jeonnam Cancer Registry, Chonnam National University Hwasun Hospital), Woo-Chul Kim (Incheon Cancer Registry, Inha University Hospital), Yune-Sik Kang (Gyeongnam Cancer Registry, Gyeongsang National University and Hospital)
• Received: March 6, 2017   • Accepted: March 6, 2017

Copyright © 2017 by the Korean Cancer Association

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

  • 25,330 Views
  • 1,163 Download
  • 304 Web of Science
  • 313 Crossref
  • 322 Scopus
prev next
  • Purpose
    This study presents the 2014 nationwide cancer statistics in Korea, including cancer incidence, survival, prevalence, and mortality.
  • Materials and Methods
    Cancer incidence data from 1999 to 2014 was obtained from the Korea National Cancer Incidence Database and followed until December 31, 2015. Mortality data from 1983 to 2014 were obtained from Statistics Korea. The prevalence was defined as the number of cancer patients alive on January 1, 2015, among all cancer patients diagnosed since 1999. Crude and age-standardized rates (ASRs) for incidence, mortality, prevalence, and 5-year relative survivals were also calculated.
  • Results
    In 2014, 217,057 and 76,611 Koreans were newly diagnosed and died from cancer respectively. The ASRs for cancer incidence and mortality in 2014 were 270.7 and 85.1 per 100,000, respectively. The all-cancer incidence rate has increased significantly by 3.4% annually from 1999 to 2012, and started to decrease after 2012 (2012-2014; annual percent change, –6.6%). However, overall cancer mortality has decreased 2.7% annually since 2002. The 5-year relative survival rate for patients diagnosed with cancer between 2010 and 2014 was 70.3%, an improvement from the 41.2% for patients diagnosed between 1993 and 1995.
  • Conclusion
    Age-standardized cancer incidence rates have decreased since 2012 and mortality rates have also declined since 2002, while 5-year survival rates have improved remarkably from 1993-1995 to 2010-2014 in Korea.
Cancer is a major life-threatening disease worldwide. Approximately 14.1 million patients were newly diagnosed with cancer and 8.2 million people died from cancer in 2012 worldwide [1]. The global burden of cancer is expected to grow rapidly due to aging population [2].
In Korea, cancer accounts for one in four deaths and more than 200,000 new cancer cases were diagnosed in 2013 [3].The number of cancer incidences and deaths are expected to increase with an aging population and westernized lifestyles [4]. Additionally, the economic burden of cancer in Korea increased approximately 1.8-fold, from $11,424 to $20,858 million, between 2000 and 2010 [5].
In this context, cancer statistics are the most important indicator to assess the national cancer burden and form cancer prevention and control strategies. This article aims to provide nationwide cancer statistics including incidence, survival, prevalence, and mortality in 2014.
1. Data sources
The Korea Central Cancer Registry (KCCR) was established by the Ministry of Health and Welfare in 1980 as a nationwide hospital-based cancer registry. Since 1999, the KCCR has collected cancer incidence data nationwide by integrating a hospital-based KCCR database with data from regional cancer registry programs. The KCCR currently provides the nationwide cancer incidence, survival, and prevalence statistics annually [6].
The KCCR built the Korea National Cancer Incidence Database (KNCI DB) from hospitals, 11 population-based registries, and additional medical chart reviews. The KNCI DB contains information regarding age, sex, region, date of diagnosis, primary cancer site, histological type, most valid diagnostic method, and SEER stage. The completeness of cancer incidence data for 2014 was estimated to be 97.8% based on the method proposed by Ajiki et al. [7]. The mid-year population and cancer mortality data from 1983 to 2014 were obtained from Statistics Korea [8]. To ascertain vital status and to calculate survival and prevalence, the KNCI DB was linked to mortality data and population registration data from Ministry of the Interior.
2. Classification
All incidence cases were registered according to the International Classification of Diseases for Oncology, 3rd edition [9] and converted to the International Classification of Diseases, 10th edition (ICD-10) [10]. The mortality cases were registered according to ICD-10. All cancer cases were reported based on the 24 cancer types.
3. Statistical analyses
Rates were expressed as crude and age-standardized rates (CR and ASR, respectively) per 100,000 individuals. The crude rate was calculated as the total number of incidence/ mortality cases divided by the mid-year population of the specified years. The ASR is a weighted average of the age-specific rates, where the weights are the proportions of persons in the corresponding age groups of a standard population [11]. In this report, ASRs were calculated using Segi’s world standard population [12]. The cumulative risk of developing cancer from birth to life expectancy was calculated using cumulative rates; that is, the sum of the age-specific rates from birth to life expectancy, as follows [13].
Cumulative risk of developing cancer from birth to life expectancy =100×1-e-cumulative rate100
Trends in incidence/mortality rates were summarized as an annual percentage change (APC) by using a Joinpoint regression. APC is the average percentage change of rates and is calculated as follows [11]:
APC=Ry+1-RyRy×100=(eb1-1)×100
, where log(Ry)=b0+b1y,
log(Ry) is the natural log transformed age standardized rates.
y=year, b0=intercept,b1=slope
The survival duration for each cancer case was determined as the interval between the date of initial diagnosis and the date of death, date of loss of follow-up, or closing date for follow-up. The 5-year relative survival rates were calculated as the ratios of the observed survival of the cancer patients to the expected survival of the general population, which was derived from the standard life table provided by Statistics Korea. Trends in 5-year relative survival rates were evaluated as percentage differences in 5-year relative survival rates from 1993-1995 and 2010-2014. Relative survival rates were calculated using the Ederer II method [14] with some minor corrections, based on an algorithm by Paul Dickman [15].
Prevalent cases were defined as the number of cancer patients alive on January 1, 2015 among all cancer patients diagnosed between 1999 and 2014. Limited-duration prevalences were calculated using SEER*Stat software. Any p-values less than 0.05 were considered statistically significant. SEER*Stat 8.2.1 (National Cancer Institute, Bethesda, MD), Joinpoint 4. 1. 1 (National Cancer Institute), and SAS 9.3 (SAS Institute, Cary, NC) were used in this report.
1. Incidence
A total of 217,057 cases were newly diagnosed with cancer during the study period (Table 1). Of these cases, 112,882 (52.0%) were men and 104,175 (48.0%) were women. Thyroid cancer was the most commonly diagnosed cancer in 2014, followed by stomach, colorectal, lung, and breast cancer in 2014. The overall cumulative risk of developing cancer from birth to life expectancy was 36.2%. However, the cumulative risk of developing cancer from birth to life expectancy was higher in men (38.7%) than in women (33.1%) (data not shown).
The total CR and ASR for overall cancer incidences in 2014 were 427.6 and 270.7 per 100,000, respectively (Table 2). According to sex, CRs for all sites combined were 444.9 per 100,000 in men and 410.3 per 100,000 in women. The ASRs were 302.2 and 255.5 per 100,000 in men and women, respectively. Stomach cancer (CR, 79.2 per 100,000) was the most common cancer in men, followed by lung (CR, 66.0 per 100,000), colorectal (CR, 63.8 per 100,000), liver (CR, 47.5 per 100,000), and prostate cancer (CR, 38.6 per 100,000). These five cancers accounted for 66.3% of newly diagnosed cases in men during the study period. In contrast, thyroid cancer (CR, 97.0 per 100,000) was the most common cancer among women, followed by breast (CR, 72.1 per 100,000), colorectal (CR, 42.5 per 100,000), stomach (CR, 38.5 per 100,000), and lung cancer (CR, 28.7 per 100,000). These five cancers accounted for 67.9% of cases in women.
2. Mortality
In 2014, the total number of deaths from cancer was 76,611, accounting for 28.6% of all deaths (Table 3). Expressed based on sex, 62.5% and 37.5% of cancer deaths occurred in men and women, respectively (Table 1).
The total CR and ASR for cancer deaths were 150.9 and 85.1 per 100,000, respectively, in 2014 (Table 4). The total CR and ASR for cancer deaths per 100,000 were higher among men (CR, 188.7; ASR, 125.8) than in women (CR, 113.2; ASR, 55.6).
According to the cancer sites, lung cancer (CR, 50.4 per 100,000) was the leading cause of death in men, followed by liver (CR, 34.0 per 100,000), stomach (CR, 22.7 per 100,000), colorectal (CR, 18.8 per 100,000), and pancreatic cancer (CR, 10.8 per 100,000). The top five causes of deaths from cancer in women included lung (CR, 18.3 per 100,000), colorectal (CR, 14.1 per 100,000), stomach (CR, 12.4 per 100,000), liver (CR, 11.6 per 100,000), and pancreatic cancer (CR, 9.3 per 100,000).
3. Trends in cancer incidence and mortality
Fig. 1 shows trends in cancer incidence and mortality from 1983 to 2014. The ASR for all-cancer incidence increased by 3.4% annually from 1999 to 2012, and then began to decrease from 2012 to 2014 (APC, –6.6%) (Table 5, Fig. 1). Cancers in stomach, colorectum, lung and thyroid started to decrease around 2011 (Table 5, Fig. 2). Especially, ASR for thyroid cancer has increased rapidly 22.4% from 1999 to 2011, but then decreased swiftly 10.8% annually starting in 2011. Incidence of breast cancer has increased constantly throughout the period, but APC was slowed from 2005. Conversely, the incidence rates of cervix and liver showed constant decrease for the whole period. The incidence rate for liver cancer has started to decrease since 1999. After 2011, decreasing rate for liver cancer was more steepen.
The ASR for all-cancer mortality rate has been increased until 2002 (Table 6, Fig. 1). After that year, it began to decrease (2002-2014; APC, –2.7%). Same patterns were shown in men and women. Most cancer sites, including lung, liver, colorectum, gallbladder, leukemia, brain and central nervous system, cervix uteri, and thyroid started to decrease in the early 2000s. However, cancers in stomach, larynx, testis, bladder, and non-Hodgkin lymphoma decreased starting in 1999 (Table 6, Fig. 3). Cancers in the pancreas, breast, and prostate showed constant increasing trends for the whole period.
4. Age-specific incidence rates
Leukemia was the most commonly diagnosed cancer among children between 0 and 14 years of age. Thyroid cancer was the most common cancer among adolescents and young adults between 15 and 34 years of age (Table 7). For men, the incidence rate of cancer increased until age 70 (Fig. 4A). Stomach cancer was the most commonly diagnosed cancer among men 35 to 64 years old, while lung cancer was the most common among men 65 and over. In contrast, thyroid cancer was most commonly diagnosed among women 35 to 64 years old, while colorectal cancer was the most common among women 65 and older. Thyroid and breast cancer showed an inverted U-shaped incidence rates by age (Fig. 4B).
5. Survival rates
The 5-year relative survival rates for all cancer combined improved remarkably in both sexes, from 41.2% in 1993-1995 to 70.3% in 2010-2014 (Table 8, Fig. 5A). After excluding thyroid cancer, the 5-year relative survival rates for all cancer still increased from 1993 to 2014 (Fig. 5B).
The 5-year relative survival rate during 2010-2014 for all cancer combined was 62.2% in men and 78.2% in women, respectively. The 5-year relative survival rate for thyroid cancer was over 100%, while the 5-year relative survival rates for testis, prostate, and breast cancer were over 90% in 2010-2014 for both sexes, respectively. However, the 5-year relative survival rate for pancreatic cancer was only 10.1% in both sexes in 2010-2014.
When compared to the 5-year relative survival rate for men in 1993-1995, prostate cancer diagnosed from 2010 to 2014 showed the most outstanding improvement, followed by stomach cancer, leukemia, lip/oral cavity/pharynx and liver cancer. Among women, stomach cancer diagnosed during 2010-2014 showed the greatest improvement in 5-year relative survival rates compared to those between 1993 and1995, followed by leukemia, non-Hodgkin lymphoma, colorectal, and liver cancer.
6. Prevalence rates
A total of 1,464,935 cancer prevalent cases were identified on January 1, 2015 (Table 1). Of these cases, 645,332 (44.1%) were men and 819,603 (55.9%) were women. The crude and age-standardized prevalence rates for cancer overall were 2,885.8 per 100,000 individuals and 1,837.6 per 100,000 individuals for both sexes, respectively, in 2014 (Table 9).
The five most common cancers for men were stomach (CR, 615.8 per 100,000), colorectal (CR, 477.1 per 100,000), prostate (CR, 245.3 per 100,000), thyroid (CR, 215.6 per 100,000), and liver cancer (CR, 170.2 per 100,000). In contrast, thyroid cancer was most common in women (CR, 1,076.8 per 100,000), followed by breast (CR, 623.5 per 100,000), colorectal (CR, 320.0 per 100,000), stomach (CR, 310.8 per 100,000), and cervix uteri cancer (CR, 178.0 per 100,000).
Analysis of the period after cancer diagnosis revealed that thyroid (20.1%) cancer was the most prevalent cancer within two years after diagnosis, followed by stomach (14.1%) and colorectal cancer (13.1%) (Fig. 6). Thyroid cancer (27.2%) was most prevalent for 2-5 years, followed by stomach (14.8%) and colorectal cancer (13.9%). After 5 years, thyroid cancer (20.4%) was the most prevalent cancer, followed by stomach (18.0%) and colorectal cancer (14.1%).

Conflict of interest relevant to this article was not reported.

Acknowledgements
This work was supported by a research grant from the National Cancer Center (No. 1610200), Republic of Korea. The authors are indebted to the Korea Central Cancer Registry (KCCR)-affiliated hospitals, non-KCCR-affiliated hospitals, the National Health Insurance Service and Statistics Korea for data collection.
Fig. 1.
Annual age-standardized cancer incidence and death rates by sex for all sites from 1983 to 2014 in Korea. Age standardization was based on the Segi’s world standard population.
crt-2017-118f1.gif
Fig. 2.
Trends in age-standardized incidences of selected cancers by sex from 1999 to 2014 in Korea. (A) Men. (B) Women. Age standardization was based on the Segi’s world standard population.
crt-2017-118f2.gif
Fig. 3.
Annual age-standardized cancer mortalities of selected cancers by sex from 1983 to 2014 in Korea. (A) Men. (B) Women. Age standardization was based on the Segi’s world standard population.
crt-2017-118f3.gif
Fig. 4.
Age-specific incidence rates of common cancers for 2014 in Korea. (A) Men. (B) Women
crt-2017-118f4.gif
Fig. 5.
Trends in relative survival by year of diagnosis from 1999 to 2014. (A) All sites for both sexes. (B) All sites except thyroid cancer for both sexes.
crt-2017-118f5.gif
Fig. 6.
Prevalence of common cancer sites by time period after cancer diagnosis. Prevalent cases were defined as the number of cancer patients alive on January 1, 2015 among all cancer patients diagnosed between 1999 and 2014.
crt-2017-118f6.gif
Table 1.
Cancer incidence, deaths, and prevalence by sex in Korea, 2014
Site/Type New cases
Deaths
Prevalent casesa)
Both sexes Men Women Both sexes Men Women Both sexes Men Women
All sites 217,057 112,882 104,175 76,611 47,869 28,742 1,464,935 645,332 819,603
Lip, oral cavity, and pharynx 3,191 2,261 930 1,097 824 273 19,687 13,253 6,434
Esophagus 2,344 2,131 213 1,540 1,407 133 8,496 7,666 830
Stomach 29,854 20,087 9,767 8,917 5,767 3,150 235,172 156,264 78,908
Colon and rectum 26,978 16,182 10,796 8,338 4,760 3,578 202,295 121,057 81,238
Liver 16,178 12,058 4,120 11,566 8,616 2,950 57,691 43,192 14,499
Gallbladderb) 5,576 2,838 2,738 3,931 1,966 1,965 17,061 8,749 8,312
Pancreas 5,948 3,191 2,757 5,116 2,752 2,364 8,472 4,539 3,933
Larynx 1,111 1,048 63 410 371 39 9,262 8,714 548
Lung 24,027 16,750 7,277 17,440 12,785 4,655 63,460 40,098 23,362
Breast 18,381 77 18,304 2,271 17 2,254 158,916 622 158,294
Cervix uteri 3,500 - 3,500 960 - 960 45,189 - 45,189
Corpus uteri 2,214 - 2,214 264 - 264 18,381 - 18,381
Ovary 2,413 - 2,413 1,021 - 1,021 16,161 - 16,161
Prostate 9,785 9,785 - 1,667 1,667 - 62,256 62,256 -
Testis 259 259 - 14 14 - 2,570 2,570 -
Kidney 4,471 3,108 1,363 944 665 279 31,610 21,404 10,206
Bladder 3,949 3,182 767 1,354 1,016 338 28,559 23,293 5,266
Brain and CNS 1,725 917 808 1,285 716 569 9,500 4,898 4,602
Thyroid 30,806 6,174 24,632 346 84 262 328,072 54,696 273,376
Hodgkin lymphoma 278 167 111 70 38 32 2,318 1,471 847
Non-Hodgkin lymphoma 4,948 2,766 2,182 1,574 910 664 31,553 16,984 14,569
Multiple myeloma 1,396 758 638 864 473 391 4,811 2,513 2,298
Leukemia 3,080 1,771 1,309 1,671 921 750 17,151 9,534 7,617
Other and ill-defined 14,645 7,372 7,273 3,951 2,100 1,851 86,292 41,559 44,733

CNS, central nervous system.

a) Limited-duration prevalent cases on January 1, 2015. These are patients who were diagnosed between January 1, 1999 and December 31, 2014 and who were alive on January 1, 2015. Multiple primary cancer cases were counted multiple times,

b) Includes the gallbladder and other/unspecified parts of the biliary tract.

Table 2.
Crude and age-standardized cancer incidence rates by sex in Korea, 2014
Site/Type Crude incidence rate per 100,000
Age-standardized incidence rate per 100,000a)
Both sexes Men Women Both sexes Men Women
All sites 427.6 444.9 410.3 270.7 302.2 255.5
Lip, oral cavity, and pharynx 6.3 8.9 3.7 4.0 6.1 2.3
Esophagus 4.6 8.4 0.8 2.8 5.5 0.4
Stomach 58.8 79.2 38.5 35.8 52.7 21.4
Colon and rectum 53.1 63.8 42.5 31.9 42.6 23.0
Liver 31.9 47.5 16.2 19.4 31.4 8.6
Gallbladderb) 11.0 11.2 10.8 6.2 7.4 5.2
Pancreas 11.7 12.6 10.9 6.7 8.4 5.4
Larynx 2.2 4.1 0.2 1.3 2.7 0.1
Lung 47.3 66.0 28.7 27.2 43.7 14.9
Breast 36.2 0.3 72.1 24.0 0.2 47.7
Cervix uteri 6.9 - 13.8 4.6 - 9.0
Corpus uteri 4.4 - 8.7 2.9 - 5.7
Ovary 4.8 - 9.5 3.3 - 6.4
Prostate 19.3 38.6 - 11.2 25.6 -
Testis 0.5 1.0 - 0.5 1.0 -
Kidney 8.8 12.2 5.4 5.7 8.4 3.3
Bladder 7.8 12.5 3.0 4.5 8.4 1.5
Brain and CNS 3.4 3.6 3.2 2.7 3.0 2.4
Thyroid 60.7 24.3 97.0 43.3 17.3 69.8
Hodgkin lymphoma 0.5 0.7 0.4 0.5 0.5 0.4
Non-Hodgkin lymphoma 9.7 10.9 8.6 6.8 8.1 5.7
Multiple myeloma 2.8 3.0 2.5 1.6 2.0 1.3
Leukemia 6.1 7.0 5.2 5.2 6.1 4.3
Other and ill-defined 28.8 29.1 28.6 18.6 21.0 16.6

CNS, central nervous system.

a) Age-adjusted using the Segi’s world standard population,

b) Includes the gallbladder and other/unspecified parts of the biliary tract.

Table 3.
The top 10 leading causes of death in Korea, 2014
Rank Cause of death No. of deaths Percentage of all deaths Age-standardized death rate per 100,000a)
All causes 267,692 100.0 295.7
1 Cancer 76,611 28.6 85.1
2 Heart disease 26,588 9.9 27.7
3 Cerebrovascular disease 24,486 9.1 24.8
4 Intentional self-harm (suicide) 13,836 5.2 19.3
5 Pneumonia 12,021 4.5 11.6
6 Diabetes mellitus 10,526 3.9 10.7
7 Chronic lower respiratory diseases 7,171 2.7 6.9
8 Disease of liver 6,635 2.5 8.0
9 Transport accidents 5,700 2.1 8.0
10 Hypertensive diseases 5,061 1.9 4.9
Others 79,057 29.5 88.8

Source: Mortality Data, 2014, Statistics Korea [8].

a) Age-adjusted using the Segi’s world standard population.

Table 4.
Crude and age-standardized cancer mortality rates by sex in Korea, 2014
Site/Type Crude mortality rate per 100,000
Age-standardized mortality rate per 100,000a)
Both sexes Men Women Both sexes Men Women
All sites 150.9 188.7 113.2 85.1 125.8 55.6
Lip, oral cavity, and pharynx 2.2 3.2 1.1 1.3 2.1 0.5
Esophagus 3.0 5.5 0.5 1.7 3.6 0.2
Stomach 17.6 22.7 12.4 9.7 15.1 5.7
Colon and rectum 16.4 18.8 14.1 9.0 12.6 6.3
Liver 22.8 34.0 11.6 13.4 22.4 5.6
Gallbladderb) 7.7 7.7 7.7 4.1 5.1 3.4
Pancreas 10.1 10.8 9.3 5.6 7.1 4.4
Larynx 0.8 1.5 0.2 0.4 1.0 0.1
Lung 34.4 50.4 18.3 18.8 33.2 8.5
Breast 4.5 0.1 8.9 2.8 0.0 5.4
Cervix uteri 1.9 - 3.8 1.1 - 2.1
Corpus uteri 0.5 - 1.0 0.3 - 0.6
Ovary 2.0 - 4.0 1.2 - 2.3
Prostate 3.3 6.6 - 1.6 4.5 -
Testis 0.0 0.1 - 0.0 0.0 -
Kidney 1.9 2.6 1.1 1.0 1.8 0.5
Bladder 2.7 4.0 1.3 1.4 2.7 0.5
Brain and CNS 2.5 2.8 2.2 1.7 2.1 1.4
Thyroid 0.7 0.3 1.0 0.4 0.2 0.4
Hodgkin lymphoma 0.1 0.1 0.1 0.1 0.1 0.1
Non-Hodgkin lymphoma 3.1 3.6 2.6 1.8 2.4 1.3
Multiple myeloma 1.7 1.9 1.5 1.0 1.2 0.8
Leukemia 3.3 3.6 3.0 2.2 2.7 1.8
Other and ill-defined 7.8 8.3 7.3 4.5 5.8 3.6

CNS, central nervous system.

a) Age-adjusted using the world standard population,

b) Includes the gallbladder and other/unspecified parts of the biliary tract.

Table 5.
Trends in cancer incidence rates from 1999 to 2014 in Korea
Site/Type Both sexes
Men
Women
1999 2014 Trend 1
Trend 2
1999 2014 Trend 1
Trend 2
1999 2014 Trend 1
Trend 2
Year APC Year APC Year APC Year APC Year APC Year APC
All sites 210.5 270.7 1999-2012 3.4a) 2012-2014 –6.6a) 285.0 302.2 1999-2011 1.7a) 2011-2014 –3.6a) 161.1 255.5 1999-2012 5.5a) 2012-2014 –7.9a)
Lip, oral cavity, and pharynx 3.6 4.0 1999-2014 0.5 - - 6.1 6.1 1999-2014 –0.3 - - 1.6 2.3 1999-2014 1.3a) - -
Esophagus 4.1 2.8 1999-2014 –2.2a) - - 8.8 5.5 1999-2014 –2.7a) - - 0.6 0.4 1999-2014 –2.0a) - -
Stomach 43.6 35.8 1999-2011 –0.1 2011-2014 –5.8a) 66.2 52.7 1999-2011 –0.3a) 2011-2014 –6.3a) 26.7 21.4 1999-2011 –0.3 2011-2014 –5.4a)
Colon and rectum 20.4 31.9 1999-2010 6.0a) 2010-2014 –4.6a) 26.2 42.6 1999-2010 6.5a) 2010-2014 –5.1a) 16.4 23.0 1999-2009 5.3a) 2009-2014 –2.5a)
Liver 27.9 19.4 1999-2011 –1.7a) 2011-2014 –5.2a) 46.8 31.4 1999-2009 –1.8a) 2009-2014 –3.8a) 12.3 8.6 1999-2011 –1.4a) 2011-2014 –6.1a)
Gallbladderb) 6.5 6.2 1999-2005 1.1 2005-2014 –1.2a) 8.1 7.4 1999-2014 –0.6a) - - 5.3 5.2 1999-2003 2.7 2003-2014 –1.2a)
Pancreas 5.6 6.7 1999-2014 1.4a) - - 7.8 8.4 1999-2014 0.7a) - - 4.0 5.4 1999-2014 2.1a) - -
Larynx 2.3 1.3 1999-2014 –3.6a) - - 4.9 2.7 1999-2014 –3.8a) - - 0.4 0.1 1999-2014 –7.1a) - -
Lung 28.5 27.2 1999-2011 0.1 2011-2014 –1.7a) 51.4 43.7 1999-2005 –0.1 2005-2014 –1.5a) 12.4 14.9 1999-2011 1.9a) 2011-2014 –0.4
Breast 10.7 24.0 1999-2005 7.6a) 2005-2014 4.5a) 0.2 0.2 1999-2014 –1.2 - - 20.9 47.7 1999-2007 7.0a) 2007-2014 4.2a)
Cervix uteri 8.5 4.6 1999-2014 –4.1a) - - - - - - - - 16.3 9.0 1999-2014 –3.9a) - -
Corpus uteri 1.4 2.9 1999-2009 6.2a) 2009-2014 3.0a) - - - - - - 2.8 5.7 1999-2009 6.4a) 2009-2014 3.1a)
Ovary 2.7 3.3 1999-2014 1.5a) - - - - - - - - 5.0 6.4 1999-2014 1.8a) - -
Prostate 3.1 11.2 1999-2009 15.1a) 2009-2014 0.6 8.4 25.6 1999-2009 13.6a) 2009-2014 –0.2 - - - - - -
Testis 0.3 0.5 1999-2014 4.8a) - - 0.6 1.0 1999-2014 4.7a) - - - - - - - -
Kidney 3.0 5.7 1999-2009 6.6a) 2009-2014 1.6a) 4.5 8.4 1999-2010 6.0a) 2010-2014 0.7 1.7 3.3 1999-2009 6.6a) 2009-2014 0.9
Bladder 4.6 4.5 1999-2004 2.4a) 2004-2014 –1.5a) 9.0 8.4 1999-2005 1.5a) 2005-2014 –1.9a) 1.6 1.5 1999-2003 2.9 2003-2014 –2.0a)
Brain and CNS 2.9 2.7 1999-2009 1.1a) 2009-2014 –2.4 3.2 3.0 1999-2009 1.3a) 2009-2014 –2.5 2.6 2.4 1999-2007 1.5a) 2007-2014 –1.7
Thyroid 6.3 43.3 1999-2011 22.4a) 2011-2014 –10.8a) 2.1 17.3 1999-2012 22.8a) 2012-2014 –16.7a) 10.4 69.8 1999-2011 22.1a) 2011-2014 –11.9a)
Hodgkin lymphoma 0.2 0.5 1999-2014 4.4a) - - 0.4 0.5 1999-2014 3.5a) - - 0.1 0.4 1999-2014 5.5a) - -
Non-Hodgkin lymphoma 4.5 6.8 1999-2014 3.4a) - - 5.8 8.1 1999-2014 2.7a) - - 3.4 5.7 1999-2011 4.7a) 2011-2014 1.0
Multiple myeloma 1.0 1.6 1999-2014 3.5a) - - 1.2 2.0 1999-2014 3.2a) - - 0.8 1.3 1999-2014 3.7a) - -
Leukemia 4.7 5.2 1999-2014 0.9a) - - 5.5 6.1 1999-2014 0.9a) - - 3.9 4.3 1999-2014 0.6a) - -
Other and ill-defined 14.3 18.6 1999-2014 2.2a) - - 17.9 21.0 1999-2014 1.6a) - - 11.8 16.6 1999-2010 3.2a) 2010-2014 0.7

APC was calculated using age-standardized incidence data based on the Segi’s world standard population. APC, annual percentage change; CNS, central nervous system.

a) Significantly different from zero (p < 0.05),

b) Includes the gallbladder and other/unspecified parts of the biliary tract.

Table 6.
Trends in cancer mortality rates from 1999 to 2014 in Korea
Site/Type Both sexes
Men
Women
1999 2014 Trend 1
Trend 2
1999 2014 Trend 1
Trend 2
1999 2014 Trend 1
Trend 2
Year APC Year APC Year APC Year APC Year APC Year APC
All sites 114.3 85.1 1999-2002 1.0 2002-2014 –2.7a) 176.6 125.8 1999-2002 1.1 2002-2014 –3.1a) 70.6 55.6 1999-2002 1.0 2002-2014 –2.2a)
Lip, oral cavity, and pharynx 1.1 1.3 1999-2014 –2.0a) - - 2.0 2.1 1999-2014 –2.2a) - - 0.4 0.5 1999-2014 –3.1a) - -
Esophagus 3.1 1.7 1999-2014 –4.5a) - - 6.8 3.6 1999-2014 –4.7a) - - 0.5 0.2 1999-2014 –5.2a) - -
Stomach 23.8 9.7 1999-2003 –3.3a) 2003-2014 –6.6a) 36.9 15.1 1999-2002 –1.3 2002-2014 –6.7a) 14.6 5.7 1999-2003 –4.4a) 2003-2014 –6.6a)
Colon and rectum 7.7 9.0 1999-2004 5.2a) 2004-2014 –1.0a) 10.5 12.6 1999-2004 5.6a) 2004-2014 –0.7a) 6.0 6.3 1999-2004 4.7a) 2004-2014 –1.7a)
Liver 20.4 13.4 1999-2002 0.7 2002-2014 –3.6a) 35.3 22.4 1999-2002 –0.2 2002-2014 –3.7a) 8.3 5.6 1999-2002 2.9a) 2002-2014 –3.7a)
Gallbladderb) 5.2 4.1 1999-2001 7.7 2001-2014 –2.8a) 6.8 5.1 1999-2001 6.7 2001-2014 –3.0a) 4.1 3.4 1999-2001 9.3 2001-2014 –2.7a)
Pancreas 5.4 5.6 1999-2014 0.3a) - - 7.6 7.1 1999-2014 –0.4a) - - 3.9 4.4 1999-2014 0.8a) - -
Larynx 1.6 0.4 1999-2014 –9.6a) - - 3.4 1.0 1999-2014 –9.1a) - - 0.4 0.1 1999-2012 –15.3a) 2012-2014 16.4
Lung 22.4 18.8 1999-2001 3.7a) 2001-2014 –1.9a) 41.5 33.2 1999-2001 4.0 2001-2014 –2.4a) 9.4 8.5 1999-2001 4.2 2001-2014 –1.4a)
Breast 2.2 2.8 1999-2014 1.4a) - - 0.1 0.0 1999-2014 –4.6a) - - 4.2 5.4 1999-2014 1.7a) - -
Cervix uteri 1.4 1.1 1999-2003 8.8a) 2003-2014 –5.5a) - - - - - - 2.6 2.1 1999-2003 8.2a) 2003-2014 –5.2a)
Corpus uteri 0.1 0.3 1999-2003 35.7a) 2003-2014 2.4a) - - - - - - 0.1 0.6 1999-2003 35.7a) 2003-2014 2.8a)
Ovary 0.9 1.2 1999-2001 10.6 2001-2014 0.3 - - - - - - 1.7 2.3 1999-2014 1.1a) - -
Prostate 0.9 1.6 1999-2002 16.1a) 2002-2014 1.2a) 2.6 4.5 1999-2002 16.7a) 2002-2014 0.7a) - - - - - -
Testis 0.0 0.0 1999-2014 –2.3 - - 0.1 0.0 1999-2014 –2.5 - - - - - - - -
Kidney 1.1 1.0 1999-2014 0.0 - - 1.8 1.8 1999-2014 0.2 - - 0.5 0.5 1999-2014 –0.8 - -
Bladder 1.3 1.4 1999-2014 –1.2a) - - 2.6 2.7 1999-2014 –1.4a) - - 0.5 0.5 1999-2001 11.1 2001-2014 –2.0a)
Brain and CNS 1.9 1.7 1999-2002 4.6 2002-2014 –2.1a) 2.2 2.1 1999-2014 –1.5a) - - 1.6 1.4 1999-2014 –1.5a) - -
Thyroid 0.4 0.4 1999-2003 6.7 2003-2014 –3.9a) 0.3 0.2 1999-2002 15.4 2002-2014 –3.7a) 0.5 0.4 1999-2004 4.1 2004-2014 –4.5a)
Hodgkin lymphoma 0.0 0.1 1999-2003 27.8a) 2003-2014 0.8 0.0 0.1 1999-2004 18.2a) 2004-2014 –1.2a) 0.0 0.1 1999-2002 56.3 2002-2014 3.5a)
Non-Hodgkin lymphoma 2.1 1.8 1999-2014 –0.9a) - - 3.0 2.4 1999-2014 –1.2 - - 1.4 1.3 1999-2014 –0.5 - -
Multiple myeloma 0.6 1.0 1999-2003 12.6a) 2003-2014 1.0 0.8 1.2 1999-2002 14.3a) 2002-2014 1.4a) 0.4 0.8 1999-2007 7.6a) 2007-2014 –1.6
Leukemia 2.9 2.2 1999-2001 1.4 2001-2014 –2.0a) 3.5 2.7 1999-2014 –1.7a) - - 2.4 1.8 1999-2014 –2.0a) - -
Other and ill-defined 7.8 4.5 1999-2014 –3.0a) - - 9.0 5.8 1999-2009 –0.5 2009-2014 –7.2a) 7.0 3.6 1999-2005 –7.1a) 2005-2014 –1.9a)

APC was calculated using age-standardized incidence data based on the Segi’s world standard population. APC, annual percentage change; CNS, central nervous system.

a) Significantly different from zero (p < 0.05),

b) Includes the gallbladder and other/unspecified parts of the biliary tract.

Table 7.
The five common sites of cancer incidence by age group and sex in Korea, 2014
Rank Age (yr)
0-14 15-34 35-64 ≥ 65
Men
 1 Leukemia (4.4) Thyroid (13.5) Stomach (86.7) Lung (445.7)
 2 Non-Hodgkin lymphoma (2.8) Non-Hodgkin lymphoma (3.2) Colon and rectum (66.0) Stomach (373.6)
 3 Brain and CNS (1.8) Colon and rectum (3.1) Liver (59.1) Colon and rectum (313.5)
 4 Liver (0.4) Leukemia (3.1) Lung (42.8) Prostate (284.2)
 5 Testis (0.3) Testis (2.1) Thyroid (38.8) Liver (192.4)
Women
 1 Leukemia (4.1) Thyroid (54.7) Thyroid (161.4) Colon and rectum (168.5)
 2 Non-Hodgkin lymphoma (2.0) Breast (11.4) Breast (129.0) Stomach (142.2)
 3 Brain and CNS (1.7) Cervix uteri (5.3) Colon and rectum (38.7) Lung (126.8)
 4 Ovary (0.8) Ovary (3.3) Stomach (37.6) Breast (73.5)
 5 Thyroid (0.6) Stomach (3.3) Lung (22.2) Liver (71.7)

CNS, central nervous system.

Table 8.
Trends in the 5-year relative survival rates (%) by year of diagnosis from 1993 to 2014 in Korea
Site/Type Both sexes
Men
Women
1993-1995 1996-2000 2001-2005 2010-2014 Changea) 1993-1995 1996-2000 2001-2005 2010-2014 Changea) 1993-1995 1996-2000 2001-2005 2010-2014 Changea)
All sites 41.2 44.0 53.9 70.3 29.1 31.7 35.3 45.3 62.2 30.5 53.4 55.3 64.0 78.2 24.8
Lip, oral cavity, and pharynx 41.1 46.7 54.2 63.5 22.4 35.8 41.1 49.4 59.8 24.0 58.1 63.8 67.8 72.4 14.3
Esophagus 12.7 15.2 21.2 35.0 22.3 11.8 14.3 20.5 34.7 22.9 23.7 24.2 29.6 37.3 13.6
Stomach 42.8 46.6 57.7 74.4 31.6 43.0 46.9 58.4 75.3 32.3 42.6 46.0 56.4 72.7 30.1
Colon and rectum 54.8 58.0 66.6 76.3 21.5 55.3 59.0 68.5 78.1 22.8 54.2 56.8 64.2 73.4 19.2
Liver 10.7 13.2 20.2 32.8 22.1 9.9 12.9 20.2 33.1 23.2 13.6 14.2 20.5 31.9 18.3
Gallbladderb) 17.3 19.7 22.8 29.2 11.9 16.6 20.3 23.4 30.1 13.5 18.0 19.1 22.4 28.4 10.4
Pancreas 9.4 7.6 8.2 10.1 0.7 8.8 7.3 8.2 9.8 1.0 10.1 8.1 8.2 10.5 0.4
Larynx 59.7 62.3 66.2 74.6 14.9 60.2 62.8 66.8 74.9 14.7 55.4 57.8 58.2 70.7 15.3
Lung 11.3 12.7 16.2 25.1 13.8 10.4 11.6 15.0 21.9 11.5 14.2 16.2 19.7 32.4 18.2
Breast 77.9 83.2 88.5 92.0 14.1 75.1 85.6 87.1 86.8 11.7 78.0 83.2 88.5 92.0 14.0
Cervix uteri 77.5 80.0 81.3 79.7 2.2 - - - - - 77.5 80.0 81.3 79.7 2.2
Corpus uteri 81.5 81.8 84.6 87.9 6.4 - - - - - 81.5 81.8 84.6 87.9 6.4
Ovary 58.7 58.9 61.5 64.1 5.4 - - - - - 58.7 58.9 61.5 64.1 5.4
Prostate 55.9 67.2 80.3 93.3 37.4 55.9 67.2 80.3 93.3 37.4 - - - - -
Testis 85.4 90.4 90.6 96.0 10.6 85.4 90.4 90.6 96.0 10.6 - - - - -
Kidney 62.0 66.1 73.4 81.3 19.3 60.8 64.4 72.8 80.8 20.0 64.5 69.7 74.5 82.5 18.0
Bladder 69.1 73.1 75.6 75.6 6.5 70.0 74.8 77.4 77.5 7.5 65.5 66.3 68.6 67.9 2.4
Brain and CNS 38.5 39.0 40.8 40.8 2.3 37.2 37.5 40.2 39.4 2.2 40.2 40.7 41.5 42.4 2.2
Thyroid 94.2 94.9 98.3 100.2 6.0 87.2 89.5 95.8 100.5 13.3 95.4 95.9 98.7 100.1 4.7
Hodgkin lymphoma 68.0 71.2 76.7 80.6 12.6 67.6 68.1 74.7 81.6 14.0 68.6 77.4 80.7 78.8 10.2
Non-Hodgkin lymphoma 46.6 50.8 59.9 69.1 22.5 45.3 48.9 58.1 67.4 22.1 48.7 53.5 62.4 71.1 22.4
Multiple myeloma 22.1 19.8 29.3 40.1 18.0 21.1 17.8 29.6 39.7 18.6 23.3 22.1 29.1 40.6 17.3
Leukemia 26.5 33.3 41.8 51.1 24.6 26.2 32.3 41.7 50.9 24.7 26.8 34.6 42.0 51.4 24.6
Other and ill-defined 42.1 45.9 56.0 69.1 27.0 37.4 42.4 52.3 65.7 28.3 47.4 50.0 60.0 72.6 25.2

CNS, central nervous system.

a) Percentage change in 5-year relative survival from 1993 to 1995 and 2010 to 2014,

b) Includes the gallbladder and other/unspecified parts of the biliary tract.

Table 9.
Crude and age-standardized rates of cancer prevalence by sex on January 1, 2015 in Korea
Site/Type Crude prevalence rate per 100,000a)
Age-standardized prevalence rate per 100,000b)
Both sexes Men Women Both sexes Men Women
All sites 2,885.8 2,543.2 3,228.2 1,837.6 1,730.9 2,027.1
Lip, oral cavity, and pharynx 38.8 52.2 25.3 25.0 35.5 15.8
Esophagus 16.7 30.2 3.3 9.9 20.0 1.7
Stomach 463.3 615.8 310.8 278.1 407.6 171.5
Colon and rectum 398.5 477.1 320.0 237.5 317.6 173.1
Liver 113.6 170.2 57.1 71.8 114.2 33.5
Gallbladderc) 33.6 34.5 32.7 19.4 22.8 16.8
Pancreas 16.7 17.9 15.5 10.2 12.1 8.7
Larynx 18.2 34.3 2.2 10.8 22.8 1.1
Lung 125.0 158.0 92.0 74.5 105.0 51.0
Breast 313.1 2.5 623.5 201.8 1.6 396.8
Cervix uteri 89.0 - 178.0 56.7 - 110.5
Corpus uteri 36.2 - 72.4 23.7 - 46.5
Ovary 31.8 - 63.7 22.2 - 44.0
Prostate 122.6 245.3 - 67.1 160.7 -
Testis 5.1 10.1 - 4.6 9.0 -
Kidney 62.3 84.4 40.2 40.2 57.5 24.9
Bladder 56.3 91.8 20.7 32.1 61.2 10.1
Brain and CNS 18.7 19.3 18.1 16.1 17.0 15.0
Thyroid 646.3 215.6 1076.8 438.4 148.2 726.7
Hodgkin lymphoma 4.6 5.8 3.3 3.8 4.8 2.9
Non-Hodgkin lymphoma 62.2 66.9 57.4 44.1 50.1 38.7
Multiple myeloma 9.5 9.9 9.1 5.8 6.6 5.1
Leukemia 33.8 37.6 30.0 31.7 35.6 28.0
Other and ill-defined 170.0 163.8 176.2 112.0 120.7 104.7

CNS, central nervous system.

a) Crude prevalence rate: number of prevalent cases divided by the corresponding person-years of observation. Prevalent cases were defined as patients who were diagnosed between January 1, 1999 and December 31, 2014 and who were alive on January 1, 2015. Multiple primary cancer cases were counted multiple times,

b) Age-adjusted using the Segi’s world standard population,

c) Includes the gallbladder and other/unspecified parts of the biliary tract.

  • 1. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN 2012 v1.0. Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon: International Agency for Research on Cancer; 2013. [cited 2017 Jan 20]. Available from:http://globocan.iarc.fr
  • 2. GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;385:117–71. ArticlePubMed
  • 3. Oh CM, Won YJ, Jung KW, Kong HJ, Cho H, Lee JK, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2013. Cancer Res Treat. 2016;48:436–50. ArticlePubMedPMCPDF
  • 4. Jung KW, Won YJ, Oh CM, Kong HJ, Cho H, Lee DH, et al. Prediction of cancer incidence and mortality in Korea, 2015. Cancer Res Treat. 2015;47:142–8. ArticlePubMedPMCPDF
  • 5. Lee KS, Chang HS, Lee SM, Park EC. Economic burden of cancer in Korea during 2000-2010. Cancer Res Treat. 2015;47:387–98. ArticlePubMedPMCPDF
  • 6. Shin HR, Won YJ, Jung KW, Kong HJ, Yim SH, Lee JK, et al. Nationwide cancer incidence in Korea, 1999~2001; first result using the national cancer incidence database. Cancer Res Treat. 2005;37:325–31. ArticlePubMedPMCPDF
  • 7. Ajiki W, Tsukuma H, Oshima A. Index for evaluating completeness of registration in population-based cancer registries and estimation of registration rate at the Osaka Cancer Registry between 1966 and 1992 using this index. Nihon Koshu Eisei Zasshi. 1998;45:1011–7. PubMed
  • 8. Statistics Korea [Internet]. Daejeon: Statistics Korea; 2016. [cited 2016 Jan 28]. Available from:http://kosis.kr
  • 9. Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin DM, et al. International classification of diseases for oncology. 3rd ed. Geneva: World Health Organization; 2000.
  • 10. World Health Organization. International statistical classification of diseases and related health problems. 10th rev. Geneva: World Health Organization; 1994.
  • 11. Howlader N, Noone AM, Krapcho M, Miller D, Bishop K, Altekruse SF, et al. SEER Cancer Statistics Review, 1975-2013 [Internet]. Bethesda, MD: National Cancer Institute; 2016. [cited 2017 Feb 20]. Available from:http://seer.cancer.gov/csr/1975_2013/
  • 12. Segi M. Cancer mortality for selected sites in 24 countries (1950-1957). Sendai: Tohoku University School of Medicine; 1960.
  • 13. Day NE. Cumulative rates and cumulative risk. In: Muir C, Waterhouse J, Mack T, Powell J, Whelan S, editors. Cancer incidence in five continents, Vol. V. IARC Scientific Publications No. 88. Lyon: International Agency for Research on Cancer; 1987. p. 787–9.
  • 14. Ederer F, Heise H. Instructions to IBM 650 programmers in processing survival computations. Methodological note No.10Bethesda, MD: National Cancer Institute; 1959.
  • 15. Paul Dickman [Internet]. Stockholm: PaulDickman.com; 2016. [cited 2016 Jan 14]. Available from:http//www.pauldickman.com

Figure & Data

REFERENCES

    Citations

    Citations to this article as recorded by  
    • Novel molecular typing reveals the risk of recurrence in patients with early-stage papillary thyroid cancer
      Mingyu Sun, Bingqing Zhao, Tao Chen, Lijun Yao, Xiaoxin Li, Shaojun Hu, Chengling Chen, Xinbao Gao, Chuangang Tang
      Thyroid Research.2024;[Epub]     CrossRef
    • Real‐world treatment patterns and clinical outcomes in patients with stage III NSCLC in Korea: The KINDLE study
      Jiyun Lee, Hee Kyung Ahn, Sang‐We Kim, Ji‐Youn Han, Sung Sook Lee, Hyung Soon Park, Hyun Woo Lee, Joo‐Hang Kim, Eunhan Cho, Reto Huggenberger, Byoung Chul Cho
      Cancer Medicine.2024;[Epub]     CrossRef
    • National Statistics of Endoscopic Submucosal Dissection for Early Gastric Cancer in Korea
      Sang Hoon Lee, Hyunseok Cho, Myoung-Nam Lim, Seung-Joo Nam
      Journal of Gastric Cancer.2024; 24(4): 464.     CrossRef
    • Incidence and treatment outcomes of uterine cervical cancer in Korea 1999–2018 from the national cancer registry
      Dong Hoon Suh, Hyeong In Ha, Yeon Jee Lee, Jiwon Lim, Young-Joo Won, Myong Cheol Lim
      Journal of Gynecologic Oncology.2023;[Epub]     CrossRef
    • Impact of Body Mass Index on Survival Depending on Sex in 14,688 Patients with Gastric Cancer in a Tertiary Hospital in South Korea
      Hyeong Ho Jo, Nayoung Kim, Jieun Jang, Yonghoon Choi, Jaehyung Park, Young Mi Park, Soyeon Ahn, Hyuk Yoon, Cheol Min Shin, Young Soo Park, Dong Ho Lee, Hyeon Jeong Oh, Hye Seung Lee, Young Suk Park, Sang-Hoon Ahn, Yun-Suhk Suh, Do Joong Park, Hyung Ho Kim
      Gut and Liver.2023; 17(2): 243.     CrossRef
    • Survival rate of thyroid cancer in the Asian countries: a systematic review and meta-analysis study
      Soheil Hassanipour, Reza Zare, Alireza Shahedi, Hamed Delam
      Endocrine.2023; 82(2): 237.     CrossRef
    • Serum ferritin is associated with sarcopenia and predicts long-term survival for gastric cancer undergoing radical gastrectomy
      Da Zhou, Chenghao Zeng, Li Zhang, Xuejin Gao, Guoli Li, Xinying Wang
      European Journal of Gastroenterology & Hepatology.2023; 35(12): 1341.     CrossRef
    • Tumour area infiltration and cell count in endoscopic biopsies of therapy-naive upper GI tract carcinomas by QuPath analysis: implications for predictive biomarker testing
      Andreas H. Scheel, Hannah Lamberty, Yuri Tolkach, Florian Gebauer, Birgid Schoemig-Markiefka, Thomas Zander, Reinhard Buettner, Josef Rueschoff, Christiane Josephine Bruns, Wolfgang Schroeder, Alexander Quaas
      Scientific Reports.2023;[Epub]     CrossRef
    • Textbook Outcome and Survival in Patients With Gastric Cancer
      Jordan Levy, Vaibhav Gupta, Elmira Amirazodi, Catherine Allen-Ayodabo, Naheed Jivraj, Yunni Jeong, Laura E. Davis, Alyson L. Mahar, Charles De Mestral, Olli Saarela, Natalie G. Coburn
      Annals of Surgery.2022; 275(1): 140.     CrossRef
    • Cause-specific mortality rate of ovarian cancer in the presence of competing risks of death: a nationwide population-based cohort study
      Seung-Hyuk Shim, Myong Cheol Lim, Dahhay Lee, Young-Joo Won, Hyeong In Ha, Ha Kyun Chang, Hyunsoon Cho
      Journal of Gynecologic Oncology.2022;[Epub]     CrossRef
    • Decisional balance, self-leadership, self-efficacy, planning, and stages of change in adopting exercise behaviors in patients with stomach cancer: A cross-sectional study
      Myung Kyung Lee
      European Journal of Oncology Nursing.2022; 56: 102086.     CrossRef
    • High prevalence of parvovirus B19 infection in patients with thyroid nodules: A case-control study
      Zahra Heidari, Mina Valinezhad
      American Journal of Otolaryngology.2022; 43(2): 103345.     CrossRef
    • A Novel One-Step Knife Approach Can Reduce the Submucosal Injection Time of Endoscopic Submucosal Dissection: A Single-Blinded Randomized Multicenter Clinical Trials
      Hyunil Kim, Jin Woo Kim, Hong Jun Park, Su Young Kim, Hyun-Soo Kim, Gwang Ho Baik, Sung Chul Park, Sang Jin Lee, Tae-Hwa Go
      Gut and Liver.2022; 16(1): 44.     CrossRef
    • Characteristics of Patients Undergoing Surgical Treatment for Spinal Metastases From Colorectal Cancer
      Se-Jun Park, Jin-Sung Park, Yunjin Nam, Chong-Suh Lee
      Clinical Spine Surgery: A Spine Publication.2022; 35(1): E187.     CrossRef
    • Better survival of patients with hepatitis B virus-related hepatocellular carcinoma in South Korea: Changes in 16-years cohorts
      Sang Il Choi, Yuri Cho, Moran Ki, Bo Hyun Kim, In Joon Lee, Tae Hyun Kim, Seong Hoon Kim, Young Hwan Koh, Hyun Beom Kim, Eun Kyung Hong, Chang-Min Kim, Joong-Won Park, Hamidreza Karimi-Sari
      PLOS ONE.2022; 17(3): e0265668.     CrossRef
    • Factors affecting the change in fruit and vegetable intake and adherence to a diet plan in patients with gastric cancer
      Myung Kyung Lee
      Asia-Pacific Journal of Oncology Nursing.2022; 9(5): 100062.     CrossRef
    • An empirical review on the risk factors, therapeutic strategies and materials at nanoscale for the treatment of oral malignancies
      Parveez Ahamed Abdul Azees, Suganthy Natarajan, Bennett T. Amaechi, Nooruddin Thajuddin, Vinay B. Raghavendra, Kathirvel Brindhadevi, Arivalagan Pugazhendhi, Tran Nhat Phuong
      Process Biochemistry.2022; 118: 283.     CrossRef
    • Association of Helicobacter pylori Infection with Papillary Thyroid Carcinoma: A Case-control Study
      Alireza Bakhshipour, Maryam Amirian, Zahra Heidari
      International Journal of Cancer Management.2022;[Epub]     CrossRef
    • Health Care Utilization and Anti-Cancer Drug Expenditure for Six Solid Cancers in Korea From 2007 to 2019
      Juhee Park, Kyeongjun Moon, Dong-Sook Kim
      Frontiers in Oncology.2022;[Epub]     CrossRef
    • Intensity- and domain-specific physical activity levels between cancer survivors and non-cancer diagnosis individuals: a propensity score matching analysis
      Jeongmin Lee, Jihee Min, Dong Hoon Lee, Dong-Woo Kang, Justin Y. Jeon
      Supportive Care in Cancer.2021; 29(2): 661.     CrossRef
    • Contribution of chemotherapy to improved prognosis in stage 4 gastric cancer: trend analysis of a regional population-based cancer registry in Japan
      Tomomi Nakao, Rena Kaneko, Hirokazu Tanaka, Shunsuke Kobayashi, Risa Omori, Yuichiro Yano, Kentaro Kamada, Takashi Ikehara, Yuzuru Sato, Yoshinori Igarashi
      International Journal of Clinical Oncology.2021; 26(2): 378.     CrossRef
    • Adherence to the Recommended Intake of Calcium and Colorectal Cancer Risk in the HEXA Study
      Jeeyoo Lee, Aesun Shin, Ji-Yeob Choi, Daehee Kang, Jong-Koo Lee
      Cancer Research and Treatment.2021; 53(1): 140.     CrossRef
    • Impact of Dyslipidemia on the Risk of Second Cancer in Thyroid Cancer Patients: A Korean National Cohort Study
      Joon Ho, Eunhwa Kim, Minkyung Han, Inkyung Jung, Jandee Lee, Young Suk Jo
      Annals of Surgical Oncology.2021; 28(8): 4373.     CrossRef
    • Risk of Suicide Attempt after Thyroidectomy: A Nationwide Population Study in South Korea
      Hyewon Kim, Yuwon Kim, Myung-Hee Shin, Kwan Woo Choi, Man Ki Chung, Hong Jin Jeon
      Psychiatry Investigation.2021; 18(1): 39.     CrossRef
    • The incidence of prostate cancer is increased in patients with obstructive sleep apnea
      Eun Jung Lee, Jeffrey D. Suh, Jae Hoon Cho
      Medicine.2021; 100(6): e24659.     CrossRef
    • Exosomal Del-1 as a Potent Diagnostic Marker for Breast Cancer: Prospective Cohort Study
      Soo Jung Lee, Jeeyeon Lee, Jin Hyang Jung, Ho Yong Park, Pyong-Gon Moon, Yee Soo Chae, Moon-Chang Baek
      Clinical Breast Cancer.2021; 21(6): e748.     CrossRef
    • Association between Moving to a High-Volume Hospital in the Capital Area and the Mortality among Patients with Cancer: A Large Population-Based Cohort Study
      Jung-kyu Choi, Se-Hyung Kim, Myung-Bae Park
      International Journal of Environmental Research and Public Health.2021; 18(7): 3812.     CrossRef
    • SQSTM1/p62 Promotes Cell Growth and Triggers Autophagy in Papillary Thyroid Cancer by Regulating the AKT/AMPK/mTOR Signaling Pathway
      Fangqin Yu, Runsheng Ma, Chenguang Liu, Lele Zhang, Kaixiang Feng, Meiqi Wang, Detao Yin
      Frontiers in Oncology.2021;[Epub]     CrossRef
    • Patient-Reported Outcomes of Regular Aerobic Exercise in Gastric Cancer
      Myung-Kyung Lee, Jihyun Oh
      Cancers.2021; 13(9): 2080.     CrossRef
    • Association between obstructive sleep apnea and thyroid cancer incidence: a national health insurance data study
      Ji Ho Choi, Jae Yong Lee, Young Chang Lim, Jin Kook Kim, Kyung Do Han, Jae Hoon Cho
      European Archives of Oto-Rhino-Laryngology.2021; 278(11): 4569.     CrossRef
    • Down-Regulation of an Autophagy-Related Gene SERPINA1 as a Superior Prognosis Biomarker Associates with Relapse and Distant Metastasis in Colon Adenocarcinoma
      Chen Fu, Zhaojin Yu, Ying He, Jian Ding, Minjie Wei
      OncoTargets and Therapy.2021; Volume 14: 3861.     CrossRef
    • Spatial interaction between breast cancer and environmental pollution in the Monterrey Metropolitan Area
      Francisco Manuel Gasca-Sanchez, Sandra Karina Santuario-Facio, Rocío Ortiz-López, Augusto Rojas-Martinez, Gerardo Manuel Mejía-Velázquez, Erick Meinardo Garza-Perez, José Ascención Hernández-Hernández, Rosa del Carmen López-Sánchez, Servando Cardona-Huert
      Heliyon.2021; 7(9): e07915.     CrossRef
    • High prevalence of thyroid carcinoma in patients with insulin resistance: a meta-analysis of case-control studies
      Junyu Zhao, Qianping Zhang, Yupeng Yang, Jinming Yao, Lin Liao, Jianjun Dong
      Aging.2021; 13(18): 22232.     CrossRef
    • Prevalence of Colorectal Polyps Based on Cardiorespiratory Fitness, Muscle Strength, Health Behavior, and Abdominal Obesity in Asymptomatic Elderly
      Shiyu Zhang, Junyong Zhang, Yonghwan Kim, Wangyang Zhang
      Healthcare.2021; 9(10): 1400.     CrossRef
    • Pattern analysis for prognosis of differentiated thyroid cancer according to preoperative serum thyrotropin levels
      Hosu Kim, Jaehoon Jung, Young-Seok Cho, Joon Young Choi, Hyunju Park, You-Bin Lee, Sun Wook Kim, Jae Hoon Chung, Tae Hyuk Kim
      Scientific Reports.2021;[Epub]     CrossRef
    • Restoration for the foregut surgery: bridging gaps between foregut surgery practice and academia
      Ye-lim Shin, Shin-Hoo Park, Yeongkeun Kwon, Chang Min Lee, Sungsoo Park
      Journal of Minimally Invasive Surgery.2021; 24(4): 175.     CrossRef
    • Protective Effect and Potential Antioxidant Role of Kakadu Plum Extracts on Alcohol-Induced Oxidative Damage in HepG2 Cells
      Reshmi Akter, Gi-Young Kwak, Jong Chan Ahn, Ramya Mathiyalagan, Zelika Mega Ramadhania, Deok Chun Yang, Se Chan Kang
      Applied Sciences.2021; 12(1): 236.     CrossRef
    • Cancer Incidence by Occupation in Korea: Longitudinal Analysis of a Nationwide Cohort
      Hye-Eun Lee, Masayoshi Zaitsu, Eun-A Kim, Ichiro Kawachi
      Safety and Health at Work.2020; 11(1): 41.     CrossRef
    • Occupational Class and Cancer Survival in Korean Men: Follow-Up Study of Nation-Wide Working Population
      Hye-Eun Lee, Masayoshi Zaitsu, Eun-A Kim, Ichiro Kawachi
      International Journal of Environmental Research and Public Health.2020; 17(1): 303.     CrossRef
    • Utility of Human Papillomavirus Testing for Cervical Cancer Screening in Korea
      Mee-seon Kim, Eun Hee Lee, Moon-il Park, Jae Seok Lee, Kisu Kim, Mee Sook Roh, Hyoun Wook Lee
      International Journal of Environmental Research and Public Health.2020; 17(5): 1726.     CrossRef
    • Body mass index and risk of breast cancer molecular subtypes in Korean women: a case–control study
      Seok Hun Jeong, Yoonsuk An, Choonghyun Ahn, Boyoung Park, Min Hyuk Lee, Dong-Young Noh, Sue K. Park
      Breast Cancer Research and Treatment.2020; 179(2): 459.     CrossRef
    • The experience of cancer‐related fatigue, exercise and exercise adherence among women breast cancer survivors: Insights from focus group interviews
      Sue Kim, Jeehee Han, Min Young Lee, Min Kyeong Jang
      Journal of Clinical Nursing.2020; 29(5-6): 758.     CrossRef
    • Effect of histologic differences between biopsy and final resection on treatment outcomes in early gastric cancer
      Yonsoo Kim, Hong Jin Yoon, Jie-Hyun Kim, Jaeyoung Chun, Young Hoon Youn, Hyojin Park, In Gyu Kwon, Seung Ho Choi, Sung Hoon Noh
      Surgical Endoscopy.2020; 34(11): 5046.     CrossRef
    • Motivators and barriers to adoption of a healthy diet by survivors of stomach cancer: A cross-sectional study
      Seung Wan Ryu, Young Gil Son, Myung Kyung Lee
      European Journal of Oncology Nursing.2020; 44: 101703.     CrossRef
    • Survival Rate of Prostate Cancer in Asian Countries: A Systematic Review and Meta-Analysis
      Soheil Hassanipour, Hamed Delam, Morteza Arab-Zozani, Elham Abdzadeh, Seyyed Ali Hosseini, Hossein-Ali Nikbakht, Mahdi Malakoutikhah, Mohammad Taghi Ashoobi, Mohammad Fathalipour, Hamid Salehiniya, Shirin Riahi
      Annals of Global Health.2020; 86(1): 2.     CrossRef
    • Radiotherapy can increase the risk of ischemic cerebrovascular disease in head and neck cancer patients: A Korean population-based cohort study
      Jin Yong Lee, Young Ae Kim, Ho Seob Kim, Joung Hwan Back, Young Ho Jung, Duk-Hyoung Lee, Suzy Kim
      Radiotherapy and Oncology.2020; 142: 85.     CrossRef
    • Statins and metachronous recurrence after endoscopic resection of early gastric cancer: a nationwide Korean cohort study
      Hyunsoo Chung, Hyun Ju Kim, Hyun Chae Jung, Sang Kil Lee, Sang Gyun Kim
      Gastric Cancer.2020; 23(4): 659.     CrossRef
    • The Impact of National Surveillance for Liver Cancer: Results from Real-World Setting in Korea
      Jin Won Kwon, Ha Jin Tchoe, Jayoun Lee, Jae Kyung Suh, Jeong-Hoon Lee, Sangjin Shin
      Gut and Liver.2020; 14(1): 108.     CrossRef
    • Clinical Factors Associated with Adherence to the Follow-Up Examination after Positive Fecal Occult Blood Test in National Colorectal Cancer Screening
      Byung Chang Kim, Minjoo Kang, Eunjung Park, Jeong-Im Shim, Shinhee Kang, Jessie Lee, Ha Jin Tchoe, Kyeong Ae Kong, Duk Hwan Kim, Yu Jin Kim, Kui Son Choi, Chang Mo Moon
      Journal of Clinical Medicine.2020; 9(1): 260.     CrossRef
    • Self-management Needs of Breast Cancer Survivors After Treatment: Results From a Focus Group Interview
      Soo Hyun Kim, Sihyun Park, Sei Joong Kim, Min Hee Hur, Bo Gyeong Lee, Mi Sook Han
      Cancer Nursing.2020; 43(1): 78.     CrossRef
    • Preoperative Serum Thyroglobulin and Its Correlation with the Burden and Extent of Differentiated Thyroid Cancer
      Hosu Kim, So Young Park, Jun-Ho Choe, Jee Soo Kim, Soo Yeon Hahn, Sun Wook Kim, Jae Hoon Chung, Jaehoon Jung, Tae Hyuk Kim
      Cancers.2020; 12(3): 625.     CrossRef
    • HER2 as a potential biomarker of lymph node metastasis in undifferentiated early gastric cancer
      Sanghoon Han, Sungjin Park, Jungsuk An, Jun-Young Yang, Jun-Won Chung, Yoon Jae Kim, Kyoung Oh Kim, Dong Kyun Park, Kwang An Kwon, Woon Kee Lee, Seungyoon Nam, Jung Ho Kim
      Scientific Reports.2020;[Epub]     CrossRef
    • Cancer incidence and survival analysis among elderly people in Bingol province
      Burak METE, Vedat SÖYİLER, Bilal BUZGAN
      Cukurova Medical Journal.2020; 45(1): 290.     CrossRef
    • Risk Factors and Clinical Outcomes of Non-Curative Resection in Patients with Early Gastric Cancer Treated with Endoscopic Submucosal Dissection: A Retrospective Multicenter Study in Korea
      Si Hyung Lee, Min Cheol Kim, Seong Woo Jeon, Kang Nyeong Lee, Jong Jae Park, Su Jin Hong
      Clinical Endoscopy.2020; 53(2): 196.     CrossRef
    • Impact of air pollution on breast cancer incidence and mortality: a nationwide analysis in South Korea
      Jeongeun Hwang, Hyunjin Bae, Seunghyun Choi, Hahn Yi, Beomseok Ko, Namkug Kim
      Scientific Reports.2020;[Epub]     CrossRef
    • Validation of the 8th Edition of the American Joint Committee on Cancer Staging System for Gallbladder Cancer and Implications for the Follow-up of Patients without Node Dissection
      You-Na Sung, Minjeong Song, Jae Hoon Lee, Ki Byung Song, Dae Wook Hwang, Chul-Soo Ahn, Shin Hwang, Seung-Mo Hong
      Cancer Research and Treatment.2020; 52(2): 455.     CrossRef
    • Cystic Lateral Lymph Node Metastases From Papillary Thyroid Cancer Patients
      Jin Kyong Kim, Min Jhi Kim, Sun Hyung Choi, Soon Min Choi, Hye Ryeon Choi, Cho Rok Lee, Sang‐Wook Kang, Jandee Lee, Jong Ju Jeong, Kee‐Hyun Nam, Woong Youn Chung
      The Laryngoscope.2020;[Epub]     CrossRef
    • Naringin Induces Lysosomal Permeabilization and Autophagy Cell Death in AGS Gastric Cancer Cells
      Suchismita Raha, Seong Min Kim, Ho Jeong Lee, Silvia Yumnam, Venu VenkatarameGowda Saralamma, Sang Eun Ha, Won Sup Lee, Gon Sup Kim
      The American Journal of Chinese Medicine.2020; 48(03): 679.     CrossRef
    • LncRNA FEZF1-AS1 promotes non-small lung cancer cell migration and invasion through the up-regulation of NOTCH1 by serving as a sponge of miR-34a
      Shangxiao Huang, Chunjun Li, Jianfeng Huang, Penghui Luo, Dunchang Mo, Hanlei Wang
      BMC Pulmonary Medicine.2020;[Epub]     CrossRef
    • Outcomes after aortic aneurysm repair in patients with history of cancer: a nationwide dataset analysis
      Sanghyun Ahn, Jin-Young Min, Hyunyoung G. Kim, Hyejin Mo, Seung-Kee Min, Sangil Min, Jongwon Ha, Kyoung-Bok Min
      BMC Surgery.2020;[Epub]     CrossRef
    • Regorafenib in previously treated advanced hepatocellular carcinoma: Impact of prior immunotherapy and adverse events
      Changhoon Yoo, Seonggyu Byeon, Yeonghak Bang, Jaekyung Cheon, Jin W. Kim, Jee H. Kim, Hong J. Chon, Beodeul Kang, Myoung J. Kang, Ilhwan Kim, Jun‐Eul Hwang, Jung H. Kang, Myung A. Lee, Jung Y. Hong, Ho Y. Lim, Baek‐Yeol Ryoo
      Liver International.2020; 40(9): 2263.     CrossRef
    • Observational Study of Peritoneal Washing Cytology-Positive Gastric Cancer without Gross Peritoneal Metastasis in Patients who Underwent Radical D2 Gastrectomy
      Hyun-Jeong Shim, Hyeon-Jong Kim, Seung Hyuk Lee, Woo-Kyun Bae, Eu-Chang Hwang, Sang-Hee Cho, Ik-Joo Chung, Hyun-Jin Bang, Jun Eul Hwang
      Scientific Reports.2020;[Epub]     CrossRef
    • Clinical impact of pre-hypertension on the risk of cancer in male and female subjects
      Su Hwan Lee, Hye Ah Lee, Sean S. Lee, Seong-Eun Kim, Ki-Nam Shim, Hye-Kyung Jung, Sung-Ae Jung, Jung Hyun Chang, Kihwan Kwon, Wook Bum Pyun, Boyoung Joung, Chang Mo Moon, Junbeom Park
      Scientific Reports.2020;[Epub]     CrossRef
    • Patterns of percutaneous transthoracic needle biopsy (PTNB) of the lung and risk of PTNB-related severe pneumothorax: A nationwide population-based study
      Bo Ram Yang, Mi-Sook Kim, Chang Min Park, Soon Ho Yoon, Kum Ju Chae, Joongyub Lee, James West
      PLOS ONE.2020; 15(7): e0235599.     CrossRef
    • Laparoscopic Surgery for Colorectal Cancer in Korea: Nationwide Data from 2013 to 2018
      Sun Jin Park, Kil Yeon Lee, Suk-Hwan Lee
      Cancer Research and Treatment.2020; 52(3): 938.     CrossRef
    • Serum fibrinogen as a diagnostic and prognostic biomarker for pancreatic ductal adenocarcinoma
      Kwang Hyun Chung, Jong-Chan Lee, Jongchan Lee, In-Kuk Cho, Jaihwan Kim, Woncheol Jang, Byong Chul Yoo, Jin-Hyeok Hwang
      Pancreatology.2020; 20(7): 1465.     CrossRef
    • Multi-Grain Rice Diet Decreases Risk of Breast Cancer in Korean Women: Results from the Health Examinees Study
      Woo-Kyoung Shin, Hwi-Won Lee, Aesun Shin, Jong-koo Lee, Sang-Ah Lee, Jung Eun Lee, Daehee Kang
      Nutrients.2020; 12(8): 2273.     CrossRef
    • Do advance directive attitudes and perceived susceptibility and end-of-life life-sustaining treatment preferences between patients with heart failure and cancer differ?
      JinShil Kim, Jiin Choi, Mi-Seung Shin, Miyeong Kim, EunJu Seo, Minjeong An, Jae Lan Shim, Seongkum Heo, Hans-Peter Brunner-La Rocca
      PLOS ONE.2020; 15(9): e0238567.     CrossRef
    • The Economic Burden of Cancers Attributable to Infection in the Republic of Korea: A Prevalence-Based Study
      Thi Xuan Trinh Nguyen, Minji Han, Moran Ki, Young Ae Kim, Jin-Kyoung Oh
      International Journal of Environmental Research and Public Health.2020; 17(20): 7592.     CrossRef
    • A prognostic study of patients with cervical cancer and HIV/AIDS in Bangkok, Thailand
      Nintita Sripaiboonkij Thokanit, Pope Kosalaraksa, Pornsuda Jitkasikorn, Tanapol Thonkamdee, Sopit Promchana, Sarikapan Wilailak
      Gynecologic Oncology Reports.2020; 34: 100669.     CrossRef
    • Body mass index and body weight change during adjuvant chemotherapy in colon cancer patients: results from the AVANT trial
      Dae-Won Lee, Sooyoung Cho, Aesun Shin, Sae-Won Han, Tae-You Kim
      Scientific Reports.2020;[Epub]     CrossRef
    • The incidence of malignant brain tumors is increased in patients with obstructive sleep apnea: A national health insurance survey
      Jae Hoon Cho, Young Chang Lim, Kyung-Do Han, Jae Yong Lee, Ji Ho Choi, Michael C. Burger
      PLOS ONE.2020; 15(11): e0241598.     CrossRef
    • YM155, specific survivin inhibitor, can enhance artesunate-induced cytotoxicity in HCT116 colon cancer cells
      Eui Tae Kim, Dong-Guk Park
      Korean Journal of Clinical Oncology.2020; 16(2): 131.     CrossRef
    • Glomerular Hyperfiltration and Cancer: A Nationwide Population-Based Study
      Yaerim Kim, Soojin Lee, Yeonhee Lee, Min Woo Kang, Sehoon Park, Sanghyun Park, Kyungdo Han, Jin Hyuk Paek, Woo Yeong Park, Kyubok Jin, Seungyeup Han, Seung Seok Han, Hajeong Lee, Jung Pyo Lee, Kwon Wook Joo, Chun Soo Lim, Yon Su Kim, Dong Ki Kim
      Cancer Epidemiology, Biomarkers & Prevention.2020; 29(10): 2070.     CrossRef
    • Randomized study to prove the quality of human ovarian tissue cryopreservation by xenotransplantation into mice
      Xiangyan Ruan, Yamei Cui, Juan Du, Jing Jin, Muqing Gu, Suwen Chen, Alfred O. Mueck
      Journal of Ovarian Research.2019;[Epub]     CrossRef
    • Vitamin D deficiency as a risk factor for thyroid cancer: A meta-analysis of case-control studies
      Junyu Zhao, Haipeng Wang, Zhongwen Zhang, Xiaojun Zhou, Jinming Yao, Rui Zhang, Lin Liao, Jianjun Dong
      Nutrition.2019; 57: 5.     CrossRef
    • Impact of sarcopenia on the risk of advanced colorectal neoplasia
      Ji Taek Hong, Tae Jun Kim, Jeung Hui Pyo, Eun Ran Kim, Sung Noh Hong, Young‐Ho Kim, Hyeon Seon Ahn, Insuk Sohn, Dong Kyung Chang
      Journal of Gastroenterology and Hepatology.2019; 34(1): 162.     CrossRef
    • Health-Related Quality of Life, Perceived Social Support, and Depression in Disease-Free Survivors Who Underwent Curative Surgery Only for Prostate, Kidney and Bladder Cancer: Comparison among Survivors and with the General Population
      Dong Wook Shin, Hyun Sik Park, Sang Hyub Lee, Seung Hyun Jeon, Seok Cho, Seok Ho Kang, Seung Chol Park, Jong Hyock Park, Jinsung Park
      Cancer Research and Treatment.2019; 51(1): 289.     CrossRef
    • The Comparison of Oncologic Outcomes between Open and Laparoscopic Radical Nephroureterectomy for the Treatment of Upper Tract Urothelial Carcinoma: A Korean Multicenter Collaborative Study
      Tae Heon Kim, Bumsik Hong, Ho Kyung Seo, Seok Ho Kang, Ja Hyeon Ku, Byong Chang Jeong
      Cancer Research and Treatment.2019; 51(1): 240.     CrossRef
    • Gender‐ and cholesterol‐specific predictive value of body mass index in renal cell carcinoma: A multicenter study
      Hyun Cheol Jeong, Fahad K. Bashraheel, Seok‐Soo Byun, Cheol Kwak, Eu Chang Hwang, Seok Ho Kang, Jinsoo Chung, Tae‐Hwan Kim, Yong‐June Kim, Sung‐Hoo Hong
      Asia-Pacific Journal of Clinical Oncology.2019;[Epub]     CrossRef
    • Treatment Patterns and Changes in Quality of Life during First-Line Palliative Chemotherapy in Korean Patients with Advanced Gastric Cancer
      Jin Won Kim, Jong Gwang Kim, Byung Woog Kang, Ik-Joo Chung, Young Seon Hong, Tae-You Kim, Hong Suk Song, Kyung Hee Lee, Dae Young Zang, Yoon Ho Ko, Eun-Kee Song, Jin Ho Baek, Dong‐Hoe Koo, So Yeon Oh, Hana Cho, Keun-Wook Lee
      Cancer Research and Treatment.2019; 51(1): 223.     CrossRef
    • The prognostic factors influencing overall survival in uterine cervical cancer with brain metastasis
      Hyera Kim, Kang Kook Lee, Mi Hwa Heo, Jin Young Kim
      The Korean Journal of Internal Medicine.2019; 34(6): 1324.     CrossRef
    • Psychiatric comorbidities among endometrial cancer survivors in South Korea: a nationwide population-based, longitudinal study
      Jaesung Heo, Mison Chun, Young-Taek Oh, O Kyu Noh
      Journal of Gynecologic Oncology.2019;[Epub]     CrossRef
    • MET is overexpressed in microsatellite instability-high gastric carcinoma
      Jongmin Sim, You Jeong Heo, Hyunsik Bae, Hyeong Chan Shin, Binnari Kim, Junhun Cho, Seung Tae Kim, Jeeyun Lee, Won Ki Kang, Kyoung-Mee Kim
      Pathology - Research and Practice.2019; 215(3): 433.     CrossRef
    • Pathologic analyses of peritoneal nodules in gastric cancer patients during surgery—A single cancer center experience with diagnostic pitfalls
      Hyunsik Bae, Hyunjin Kim, Jinah Chu, Yunjeong Jang, Hyun Hee Koh, Hera Jung, Sang Yun Ha, Kee-Taek Jang, Kyoung-Mee Kim
      Pathology - Research and Practice.2019; 215(1): 195.     CrossRef
    • Increased Risk of Osteoporosis in Gastric Cancer Survivors Compared to General Population Control: A Study with Representative Korean Population
      Su-Min Jeong, Dong Wook Shin, Ji Eun Lee, Sang-Man Jin, Sung Kim
      Cancer Research and Treatment.2019; 51(2): 530.     CrossRef
    • Health-Related Quality of Life Changes in Prostate Cancer Patients after Radical Prostatectomy: A Longitudinal Cohort Study
      Dong Wook Shin, Sang Hyub Lee, Tae-Hwan Kim, Seok Joong Yun, Jong Kil Nam, Seung Hyun Jeon, Seung Chol Park, Seung Il Jung, Jong-Hyock Park, Jinsung Park
      Cancer Research and Treatment.2019; 51(2): 556.     CrossRef
    • Clinical Outcomes of EGFR Exon 20 Insertion Mutations in Advanced Non-small Cell Lung Cancer in Korea
      Seonggyu Byeon, Youjin Kim, Sung Won Lim, Jang Ho Cho, Sehoon Park, Jiyun Lee, Jong-Mu Sun, Yoon-La Choi, Se-Hoon Lee, Jin Seok Ahn, Keunchil Park, Myung-Ju Ahn
      Cancer Research and Treatment.2019; 51(2): 623.     CrossRef
    • The discovery of a novel eight‐mRNA‐lncRNA signature predicting survival of hepatocellular carcinoma patients
      Ye‐Min Shi, Yan‐Yan Li, Jia‐Yun Lin, Lei Zheng, Yi‐Ming Zhu, Jian Huang
      Journal of Cellular Biochemistry.2019; 120(5): 7539.     CrossRef
    • Disparities in the Diagnosis and Treatment of Lung Cancer among People with Disabilities
      Dong Wook Shin, Jong Ho Cho, Jae Myoung Noh, Hyesook Han, Kyungdo Han, Sang Hyun Park, So Young Kim, Jong Heon Park, Jong Hyock Park, Ichiro Kawachi
      Journal of Thoracic Oncology.2019; 14(2): 163.     CrossRef
    • Safety and efficacy of trastuzumab administered as a 30-min infusion in patients with HER2-positive advanced gastric cancer
      Sung Yong Oh, Suee Lee, Seok Jae Huh, Jeeyun Lee, Seung Tae Kim, Se Hoon Park, Ho Yeong Lim, Won Ki Kang, Byung Woog Kang, Jong Gwang Kim, Hyo Jin Lee, Jung Hoon Kim, Jung Hun Kang, HoUng Kim
      Cancer Chemotherapy and Pharmacology.2019; 83(3): 501.     CrossRef
    • Increased prevalence of metabolic syndrome in adult cancer survivors: Asian first report in community setting
      Minkyung Kim, In-Hoo Kim, Min Kyung Lim, Yeol Kim, Boyoung Park
      Cancer Epidemiology.2019; 58: 130.     CrossRef
    • Ki-67 labeling index as a prognostic marker in advanced stomach cancer
      Sang Hyuk Seo, Kwang Hee Kim, Sang Hoon Oh, Yunseon Choi, Ki Jung Ahn, Ji Young Lee, Sang Min Lee, Jisun Park, Woo Gyeong Kim
      Annals of Surgical Treatment and Research.2019; 96(1): 27.     CrossRef
    • Long-Term Experience of Sperm Cryopreservation in Cancer Patients in a Single Fertility Center
      Seung-Hun Song, Dae Keun Kim, Su Ye Sung, Young Sun Her, Ok-Hee Lee, Myoung Hwa Choi, Hae Kyung Kim, Sang Woo Lyu, Dong Suk Kim
      The World Journal of Men's Health.2019; 37(2): 219.     CrossRef
    • Association between awareness of nutrition labeling and high-density lipoprotein cholesterol concentration in cancer survivors and the general population: The Korean National Health and Nutrition Examination Survey (KNHANES) 2010–2016
      Ji Sung Yoo, Kyu-Tae Han, Seung Hyun Chung, Eun-Cheol Park
      BMC Cancer.2019;[Epub]     CrossRef
    • Unexpected malignant uterine pathology: Incidence, characteristics and outcome in a large single-center series of hysterectomies for presumed benign uterine disease
      P. Wagner, F.K.F. Kommoss, S. Kommoss, A.D. Hartkopf, I. Pasternak, E. Oberlechner, K. Greif, M. Wallwiener, F. Neis, H. Abele, B. Krämer, C. Reisenauer, A. Staebler, D. Wallwiener, S.Y. Brucker, F.A. Taran
      Gynecologic Oncology.2019; 153(1): 49.     CrossRef
    • Randomized Phase III Trial of Irinotecan Plus Cisplatin versus Etoposide Plus Cisplatin in Chemotherapy-Naïve Korean Patients with Extensive-Disease Small Cell Lung Cancer
      Dong-Wan Kim, Hoon-Gu Kim, Joo-Hang Kim, Keunchil Park, Hoon-Kyo Kim, Joung Soon Jang, Bong-Seog Kim, Jin-Hyoung Kang, Kyung Hee Lee, Sang-We Kim, Hun Mo Ryoo, Jin-Soo Kim, Ki Hyeong Lee, Jung Hye Kwon, Jin-Hyuk Choi, Sang Won Shin, Seokyung Hahn, Dae Seo
      Cancer Research and Treatment.2019; 51(1): 119.     CrossRef
    • Clinical Features and Association with Visceral Malignancy in 80 Patients with Sebaceous Neoplasms
      Jee Eun Kim, Jong Hoon Kim, Kee-Yang Chung, Jin Sook Yoon, Mi Ryung Roh
      Annals of Dermatology.2019; 31(1): 14.     CrossRef
    • Prognostic significance of pretreatment lymphocyte percentage and age at diagnosis in patients with locally advanced cervical cancer treated with definite radiotherapy
      Myung-Hwa Jeong, Hyungjoo Kim, Tae-Hun Kim, Moon-Hong Kim, Beob-Jong Kim, Sang-Young Ryu
      Obstetrics & Gynecology Science.2019; 62(1): 35.     CrossRef
    • Cross-national analysis about the difference of histopathological management in Tis and T1 colorectal cancer between Japan and Korea
      Naohisa Yoshida, Yuji Naito, Yutaka Inada, Yoshito Itoh, Sang Pyo Lee, Jeong Hwan Kim, In-Kyung Sung, Hyung Seok Park, Hye Seung Han, Masayoshi Nakanishi, Mitsuo Kishimoto, Sun-Young Lee
      Journal of the Anus, Rectum and Colon.2019; 3(1): 18.     CrossRef
    • Development of a risk scoring system for patients with papillary thyroid cancer
      Kyoungjune Pak, Yun Hak Kim, Sunghwan Suh, Tae Sik Goh, Dae Cheon Jeong, Seong Jang Kim, In Joo Kim, Myoung‐Eun Han, Sae‐Ock Oh
      Journal of Cellular and Molecular Medicine.2019; 23(4): 3010.     CrossRef
    • Symptom experiences and health‐related quality of life among non‐small cell lung cancer patients participating in clinical trials
      Kyunghwa Lee, Eui Geum Oh, Sanghee Kim, Sang‐We Kim
      Journal of Clinical Nursing.2019; 28(11-12): 2111.     CrossRef
    • Adult height in relation to risk of cancer in a cohort of 22,809,722 Korean adults
      Yoon Jin Choi, Dong Ho Lee, Kyung-Do Han, Hyuk Yoon, Cheol Min Shin, Young Soo Park, Nayoung Kim
      British Journal of Cancer.2019; 120(6): 668.     CrossRef
    • Association of Periodontitis with Oral Cancer: A Case-Control Study
      Y.J. Shin, H.W. Choung, J.H. Lee, I.C. Rhyu, H.D. Kim
      Journal of Dental Research.2019; 98(5): 526.     CrossRef
    • Economic burden of lung cancer: A retrospective cohort study in South Korea, 2002-2015
      Soo Min Jeon, Jin-Won Kwon, Sun Ha Choi, Hae-Young Park, Seil Sohn
      PLOS ONE.2019; 14(2): e0212878.     CrossRef
    • Relationship Between Preferences for Advance Directive Treatments and Decisional Conflicts Among Low-Income, Home-Based Cancer Management Recipients in Korea
      Miyeong Kim, Seongkum Heo, Jung-Yi Hur, JaeLan Shim, JinShil Kim
      Journal of Transcultural Nursing.2019; 30(6): 587.     CrossRef
    • Clinical Outcomes of Conversion Surgery after Neoadjuvant Chemotherapy in Patients with Borderline Resectable and Locally Advanced Unresectable Pancreatic Cancer: A Single-Center, Retrospective Analysis
      Changhoon Yoo, Sang Hyun Shin, Kyu-pyo Kim, Jae Ho Jeong, Heung-Moon Chang, Jun Ho Kang, Sang Soo Lee, Do Hyun Park, Tae Jun Song, Dong Wan Seo, Sung Koo Lee, Myung-Hwan Kim, Jin-hong Park, Dae Wook Hwang, Ki Byung Song, Jae Hoon Lee, Baek-Yeol Ryoo, Song
      Cancers.2019; 11(3): 278.     CrossRef
    • Association of body mass index with bladder cancer risk in men depends on abdominal obesity
      Jin Bong Choi, Jung Ho Kim, Sung-Hoo Hong, Kyung-Do Han, U-Syn Ha
      World Journal of Urology.2019; 37(11): 2393.     CrossRef
    • Prevalence of Pressure Injuries Nationwide from 2009 to 2015: Results from the National Inpatient Sample Database in Korea
      Gyeong Hoe Kim, Jin Yong Lee, Jayeun Kim, Hyun Joo Kim, Ji-Ung Park
      International Journal of Environmental Research and Public Health.2019; 16(5): 704.     CrossRef
    • Changes in Bone Mineral Density in Women With Breast Cancer
      Soo Hyun Kim, Young Up Cho, Sei Joong Kim, Mi Sook Han
      Cancer Nursing.2019; 42(2): 164.     CrossRef
    • The economic burden of cancers attributable to smoking in Korea, 2014
      Thi Nguyen, Minji Han, Jin-Kyoung Oh
      Tobacco Induced Diseases.2019;[Epub]     CrossRef
    • Incidence and Mortality Rates of Second Pancreatic Cancer Among Survivors of Digestive Cancers
      Hyeong Sik Ahn, Tae Uk Kang, Heather Swan, Min Ji Kang, Nayoung Kim, Hyun Jung Kim, Seon Mee Park
      Pancreas.2019; 48(3): 412.     CrossRef
    • Prediction of Recurrence With KRAS Mutational Burden Using Ultrasensitive Digital Polymerase Chain Reaction of Radial Resection Margin of Resected Pancreatic Ductal Adenocarcinoma
      Sung Joo Kim, Mi-Ju Kim, Ji-Soo Han, You-Na Sung, Soyeon An, Jae Hoon Lee, Ki Byung Song, Dae Wook Hwang, Sang Soo Lee, HyungJun Cho, Song Cheol Kim, James R. Eshleman, Seung-Mo Hong
      Pancreas.2019; 48(3): 400.     CrossRef
    • Evaluation of satisfaction with three different cervical cancer screening modalities: clinician-collected Pap test vs. HPV test by self-sampling vs. HPV test by urine sampling
      Hye Young Shin, Bomyee Lee, Sang-Hyun Hwang, Dong Ock Lee, Na Young Sung, Jae Young Park, Jae Kwan Jun
      Journal of Gynecologic Oncology.2019;[Epub]     CrossRef
    • Genomic Characterization of Differentiated Thyroid Carcinoma
      Young Shin Song, Young Joo Park
      Endocrinology and Metabolism.2019; 34(1): 1.     CrossRef
    • Risk factors associated with locoregional failure and estimation of survival after curative resection for patients with distal bile duct cancer
      Jung Ho Im, Joon Seong Park, Dong Sup Yoon, Dong Ki Lee, Jun Won Kim, Ik Jae Lee
      Scientific Reports.2019;[Epub]     CrossRef
    • Preoperative neutrophil-lymphocyte ratio and CEA is associated with poor prognosis in patients with synchronous colorectal cancer liver metastasis
      Hyunjung Kim, Hae Il Jung, Soon Ha Kwon, Sang Ho Bae, Hyung Chul Kim, Moo-Jun Baek, Moon Soo Lee
      Annals of Surgical Treatment and Research.2019; 96(4): 191.     CrossRef
    • Specific protein 1(SP1) regulates the epithelial-mesenchymal transition via lysyl oxidase-like 2(LOXL2) in pancreatic ductal adenocarcinoma
      Im-kyung Kim, Yun Sun Lee, Hyung Sun Kim, Seung Myung Dong, Joon Seong Park, Dong Sup Yoon
      Scientific Reports.2019;[Epub]     CrossRef
    • Salvage Concurrent Chemo-radiation Therapy for Loco-regional Recurrence Following Curative Surgery of Non-small Cell Lung Cancer
      Kyung Hwa Lee, Yong Chan Ahn, Hongryull Pyo, Jae Myoung Noh, Seung Gyu Park, Tae Gyu Kim, Eonju Lee, Heerim Nam, Hyebin Lee, Jong-Mu Sun, Jin Seok Ahn, Myung-Ju Ahn, Keunchil Park
      Cancer Research and Treatment.2019; 51(2): 769.     CrossRef
    • Phase I Dose-Finding Study of OPB-111077, a Novel STAT3 Inhibitor, in Patients with Advanced Hepatocellular Carcinoma
      Changhoon Yoo, Jihoon Kang, Ho Yeong Lim, Jee Hyun Kim, Myung-Ah Lee, Kyung-Hun Lee, Tae-You Kim, Baek-Yeol Ryoo
      Cancer Research and Treatment.2019; 51(2): 510.     CrossRef
    • Incidence and Overall Survival of Biliary Tract Cancers in South Korea from 2006 to 2015: Using the National Health Information Database
      Byung-Woo Kim, Chang-Mo Oh, Hwa Young Choi, Joong-Won Park, Hyunsoon Cho, Moran Ki
      Gut and Liver.2019; 13(1): 104.     CrossRef
    • A retrospective feasibility study of biweekly docetaxel in patients with high-risk metastatic castration-naïve prostate cancer
      Sang Eun Yoon, Youjin Kim, Jangho Cho, Minyong Kang, Hyun Hwan Sung, Hwang Gyun Jeon, Byoung Chang Jeong, Seong Il Seo, Seong Soo Jeon, Hyun Moo Lee, Han Yong Choi, Su Jin Lee, Se Hoon Park
      BMC Urology.2019;[Epub]     CrossRef
    • Risk of cancer in pre-dialysis chronic kidney disease: A nationwide population-based study with a matched control group
      Sehoon Park, Soojin Lee, Yaerim Kim, Yeonhee Lee, Min Woo Kang, Kyungdo Han, Seoung Seok Han, Hajeong Lee, Jung Pyo Lee, Kwon Wook Joo, Chun Soo Lim, Yon Su Kim, Dong Ki Kim
      Kidney Research and Clinical Practice.2019; 38(1): 60.     CrossRef
    • The economic burden of cancer attributable to obesity in Korea: A population‐based cohort study
      Joo Eun Lee, Chung Mo Nam, Sang Gyu Lee, Sohee Park, Tae Hyun Kim, Eun‐Cheol Park
      European Journal of Cancer Care.2019;[Epub]     CrossRef
    • Factors for the Early Revision of Misdiagnosed Tuberculosis to Lung Cancer: A Multicenter Study in A Tuberculosis-Prevalent Area
      Chin-Chung Shu, Shih-Chieh Chang, Yi-Chun Lai, Cheng-Yu Chang, Yu-Feng Wei, Chung-Yu Chen
      Journal of Clinical Medicine.2019; 8(5): 700.     CrossRef
    • Safety of Laparoscopic Oncologic Resection in Elderly Patients with Colorectal Cancer: A Multicenter Retrospective Study Based on Perioperative Short-Term Outcomes
      Bong-Hyeon Kye, Thammanij Rookkachart, Ji-Hoon Kim, Hyung-Jin Kim, Yoon-Suk Lee, In-Kyu Lee, Won Kyung Kang, Hyeon-Min Cho, Seong-Taek Oh
      Journal of Laparoendoscopic & Advanced Surgical Techniques.2019; 29(8): 1016.     CrossRef
    • Performance Evaluation of SENTiFIT 270 and FOB Gold Reagent for Detecting Fecal Occult Blood
      Da Young Kang, Dokyun Kim, Keonhan Kim, In-Ho Jang, Seok Hoon Jeong
      Annals of Clinical Microbiology.2019; 22(2): 29.     CrossRef
    • Expression of NF2 Modulates the Progression of BRAF V600E Mutated Thyroid Cancer Cells
      Mi-Hyeon You, Min Ji Jeon, Tae Yong Kim, Won Bae Kim, Young Kee Shong, Won Gu Kim
      Endocrinology and Metabolism.2019; 34(2): 203.     CrossRef
    • Integrative cancer treatment may have a survival benefit in patients with lung cancer
      Kyeore Bae, Eunseok Kim, Ji-Sook Kong, Jeehye Kim, So-jung Park, Hyeong joon Jun, Chong-kwan Cho, Mi Kyung Kim, Hwa-Seung Yoo
      Medicine.2019; 98(26): e16048.     CrossRef
    • Current status of endoscopic submucosal dissection for early gastric cancer in Korea: role and benefits
      Sang Gyun Kim, Da Hyun Lyu, Chan Mi Park, Na Rae Lee, Jiyoung Kim, Youngju Cha, Hwoon-Yong Jung
      The Korean Journal of Internal Medicine.2019; 34(4): 785.     CrossRef
    • Clinical Features and Outcomes of Invasive Breast Cancer: Age-Specific Analysis of a Modern Hospital-Based Registry
      Ji-Yeon Kim, Danbee Kang, Seok Jin Nam, Seok Won Kim, Jeong Eon Lee, Jong Han Yu, Se Kyung Lee, Young-Hyuck Im, Jin Seok Ahn, Eliseo Guallar, Juhee Cho, Yeon Hee Park
      Journal of Global Oncology.2019; (5): 1.     CrossRef
    • The Korean–Advance Directive Model and Factors Associated With Its Completion Among Patients With Hematologic Disorders
      Mee Ok Lee, Jinny Park, Eun Young Park, Youngji Kim, Eunjoo Bang, Seongkum Heo, JinShil Kim
      Journal of Hospice & Palliative Nursing.2019; 21(4): E10.     CrossRef
    • Association between Body Mass Index and Gastric Cancer Risk According to Effect Modification by Helicobacter pylori Infection
      Jieun Jang, Eun-Jung Cho, Yunji Hwang, Elisabete Weiderpass, Choonghyun Ahn, Jeoungbin Choi, Soung-Hoon Chang, Hai-Rim Shin, Min Kyung Lim, Keun-Young Yoo, Sue K. Park
      Cancer Research and Treatment.2019; 51(3): 1107.     CrossRef
    • Clinical and Genetic Characteristics of BRCA1/2 Mutation in Korean Ovarian Cancer Patients: A Multicenter Study and Literature Review
      Byung Su Kwon, Jung Mi Byun, Hyun Joo Lee, Dae Hoon Jeong, Tae Hwa Lee, Kyung-Hwa Shin, Dong Soo Suh, Ki Hyung Kim
      Cancer Research and Treatment.2019; 51(3): 941.     CrossRef
    • The Health Burden of Cancer Attributable to Obesity in Korea: A Population-Based Cohort Study
      Joo Eun Lee, Chung Mo Nam, Sang Gyu Lee, Sohee Park, Tae Hyun Kim, Eun-Cheol Park
      Cancer Research and Treatment.2019; 51(3): 933.     CrossRef
    • Interventional radiology for post-gastrectomy complications
      Suyoung Park, Ji Hoon Shin, Kichang Han
      International Journal of Gastrointestinal Intervention.2019; 8(3): 145.     CrossRef
    • The burdens of tuberculosis on patients with malignancy: incidence, mortality and relapse
      Chin-Chung Shu, Kuang-Ming Liao, Yi-Chen Chen, Jhi-Joung Wang, Chung-Han Ho
      Scientific Reports.2019;[Epub]     CrossRef
    • Comprehensive Cancer Panel Sequencing Defines Genetic Diversity and Changes in the Mutational Characteristics of Pancreatic Cancer Patients Receiving Neoadjuvant Treatment
      Kyong-Ah Yoon, Sang Myung Woo, Yun-Hee Kim, Sun-Young Kong, Min Kyoung Lee, Sung-Sik Han, Tae Hyun Kim, Woo Jin Lee, Sang-Jae Park
      Gut and Liver.2019; 13(6): 683.     CrossRef
    • Effect of Different Types of Mammography Equipment on Screening Outcomes: A Report by the Alliance for Breast Cancer Screening in Korea
      Bo Hwa Choi, Eun Hye Lee, Jae Kwan Jun, Keum Won Kim, Young Mi Park, Hye-Won Kim, You Me Kim, Dong Rock Shin, Hyo Soon Lim, Jeong Seon Park, Hye Jung Kim
      Korean Journal of Radiology.2019; 20(12): 1638.     CrossRef
    • Amenorrhea and Menopause in Patients with Breast Cancer after Chemotherapy
      Jae Jun Shin, Young Min Choi, Jong Kwan Jun, Kyung-Hun Lee, Tae-Yong Kim, Wonshik Han, Seock-Ah Im
      Journal of Breast Cancer.2019; 22(4): 624.     CrossRef
    • Predictors of Quality of Life and Social Support as a Mediator between Defecation Function and Quality of Life among Rectal Cancer Patients
      Jung Rang Kim, Seon Young Hwang
      Korean Journal of Adult Nursing.2019; 31(5): 487.     CrossRef
    • Psychometric Evaluation of a Korean Version of the Cancer Survivors' Self-efficacy Scale
      Soo Hyun Kim, Bo Gyeong Lee, Ji Yeon Lee, Sei Joong Kim, Min Hee Hur, Moon Hee Lee, Mi Sook Han
      Cancer Nursing.2019; 42(6): 509.     CrossRef
    • Do disinfection byproducts in drinking water have an effect on human cancer risk worldwide? A meta‐analysis
      Laleh R. Kalankesh, Susana Rodríguez‐Couto, Mohammad Ali Zazouli, Mahmood Moosazadeh, Seyednouraddin Mousavinasab
      Environmental Quality Management.2019; 29(2): 105.     CrossRef
    • Relationship between occupational sunlight exposure and the incidence of renal cancer
      Hyun-Suk Jang, Jong-Han Leem, Seong Soo Jeon, Shin-Goo Park, Sangyoon Lee, Yangwon Kang, Go Choi, Hyung Doo Kim, Hyeonwoo Ju, Sung Wook Jang, Youna Won, Hwan-Cheol Kim
      Annals of Occupational and Environmental Medicine.2019;[Epub]     CrossRef
    • Correlates of life-support treatment preferences among low-income home-based cancer management recipients
      JinShil Kim, Seongkum Heo, Mi Yeong Kim, Eun Young Park, Eun Ju Seo, Mee Ok Lee, Bo Yoon Jeong, Jung-Ah Lee
      European Journal of Oncology Nursing.2019; 43: 101665.     CrossRef
    • Clinical outcomes of early gastric cancer with non-curative resection after pathological evaluation based on the expanded criteria
      Hyun Ju Kim, Sang Gyun Kim, Jung Kim, Hyoungju Hong, Hee Jong Lee, Min Seong Kim, Hyunsoo Chung, Hyun Chae Jung, Sudeep Gupta
      PLOS ONE.2019; 14(10): e0224614.     CrossRef
    • Association between obstructive sleep apnoea and breast cancer: The Korean National Health Insurance Service Data 2007–2014
      Ji Ho Choi, Jae Yong Lee, Kyung Do Han, Young Chang Lim, Jae Hoon Cho
      Scientific Reports.2019;[Epub]     CrossRef
    • Risk of Cancers in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Results from the Korea National Health Insurance Claims Database 2010–2018
      Sung Soo Ahn, Minkyung Han, Juyoung Yoo, Seung Min Jung, Jason Jungsik Song, Yong-Beom Park, Inkyung Jung, Sang-Won Lee
      Journal of Clinical Medicine.2019; 8(11): 1871.     CrossRef
    • A Text Mining Analysis of HPV Vaccination Research Trends
      Yedong Son, Hee Sun Kang
      Child Health Nursing Research.2019; 25(4): 458.     CrossRef
    • A Survey on Current Trends of Breast Imaging Practices in Korea
      Bo La Yun, Sun Mi Kim, Mijung Jang, Nariya Cho, Boo-Kyung Han
      Journal of the Korean Society of Radiology.2019; 80(5): 919.     CrossRef
    • Resveratrol induces cell death through ROS‑dependent downregulation of Notch1/PTEN/Akt signaling in ovarian cancer cells
      Thae Kim, Ji Park, Jae Woo
      Molecular Medicine Reports.2019;[Epub]     CrossRef
    • Pro‑apoptotic effect of the novel benzylidene derivative MHY695 in human colon cancer cells
      Gwangbeom Heo, Dongwan Kang, Chaeun Park, Su Kim, Jieun Choo, Yunna Lee, Jin‑Wook Yoo, Yunjin Jung, Jaewon Lee, Nam Kim, Hae Chung, Hyung Moon, Eunok Im
      Oncology Letters.2019;[Epub]     CrossRef
    • Smoking and Urinary Cotinine Levels Are Predictors of Increased Risk for Gastric Intestinal Metaplasia
      Kyungeun Kim, Yoosoo Chang, Jiin Ahn, Hyo-Joon Yang, Ju Young Jung, Seokkyun Kim, Chong Il Sohn, Seungho Ryu
      Cancer Research.2019; 79(3): 676.     CrossRef
    • Cancer Risk from Exposure to Particulate Matter and Ozone According to Obesity and Health-Related Behaviors: A Nationwide Population-Based Cross-Sectional Study
      Kyoung Jin Kim, Jinyoung Shin, Jaekyung Choi
      Cancer Epidemiology, Biomarkers & Prevention.2019; 28(2): 357.     CrossRef
    • Body Mass Index and Risk of Intestinal Metaplasia: A Cohort Study
      Kyungeun Kim, Yoosoo Chang, Jiin Ahn, Hyo-Joon Yang, Ju Young Jung, Seokkyun Kim, Chong Il Sohn, Seungho Ryu
      Cancer Epidemiology, Biomarkers & Prevention.2019; 28(4): 789.     CrossRef
    • A Nationwide, Population-Based Epidemiologic Study of Childhood Brain Tumors in Korea, 2005–2014: A Comparison with United States Data
      Ji-Man Kang, Johyun Ha, Eun Kyung Hong, Hee Young Ju, Byung Kiu Park, Sang-Hoon Shin, Young-Joo Won, Kyu-Won Jung, Hyeon Jin Park
      Cancer Epidemiology, Biomarkers & Prevention.2019; 28(2): 409.     CrossRef
    • A psychological intervention programme for patients with breast cancer under chemotherapy and at a high risk of depression: A randomised clinical trial
      Yeon Hee Kim, Kyung Sook Choi, Kihye Han, Hae Won Kim
      Journal of Clinical Nursing.2018; 27(3-4): 572.     CrossRef
    • Necessity of D2 lymph node dissection in older patients ≥ 80 years with gastric cancer
      Ho Seok Seo, Yoon Ju Jung, Ji Hyun Kim, Cho Hyun Park, Han Hong Lee
      Journal of Geriatric Oncology.2018; 9(2): 115.     CrossRef
    • Mapping patterns of locoregional recurrence following contemporary treatment with radiation therapy for breast cancer: A multi-institutional validation study of the ESTRO consensus guideline on clinical target volume
      Jee Suk Chang, Jeongshim Lee, Mison Chun, Kyung Hwan Shin, Won Park, Jong Hoon Lee, Jin Hee Kim, Won Sup Yoon, Ik Jae Lee, Juree Kim, Hye Li Park, Yong Bae Kim
      Radiotherapy and Oncology.2018; 126(1): 139.     CrossRef
    • Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in the Republic of Korea, 2014–2016
      Yung-Taek Ouh, Kyung-Jin Min, Hyun Woong Cho, Moran Ki, Jin-Kyoung Oh, Sang Yop Shin, Jin Hwa Hong, Jae-Kwan Lee
      Journal of Gynecologic Oncology.2018;[Epub]     CrossRef
    • Apoptotic and antiproliferative properties of 3β‐hydroxy‐Δ5‐steroidal congeners from a partially purified column fraction of Dendronephthya gigantea against HL‐60 and MCF‐7 cancer cells
      I. P. Shanura Fernando, K. K. Asanka Sanjeewa, Hyun‐Soo Kim, Lei Wang, Won Woo Lee, You‐Jin Jeon
      Journal of Applied Toxicology.2018; 38(4): 527.     CrossRef
    • Cancer incidence in northern Thailand: Results from six population‐based cancer registries 1993–2012
      Donsuk Pongnikorn, Karnchana Daoprasert, Narate Waisri, Mathieu Laversanne, Freddie Bray
      International Journal of Cancer.2018; 142(9): 1767.     CrossRef
    • Incidental Anterior Mediastinal Nodular Lesions on Chest CT in Asymptomatic Subjects
      Soon Ho Yoon, Seung Ho Choi, Chang Hyun Kang, Jin Mo Goo
      Journal of Thoracic Oncology.2018; 13(3): 359.     CrossRef
    • Changes in Clinical Characteristics of Patients with an Initial Diagnosis of Prostate Cancer in Korea: 10-Year Trends Reported by a Tertiary Center
      Ji Eun Heo, Hyun Kyu Ahn, Jinu Kim, Byung Ha Chung, Kwang Suk Lee
      Journal of Korean Medical Science.2018;[Epub]     CrossRef
    • Phase II study of oxaliplatin, irinotecan and S-1 therapy in patients with advanced gastric cancer: the Korean Cancer Study Group ST14-11
      Hyeong Su Kim, Min-Hee Ryu, Dae Young Zang, Sook Ryun Park, Boram Han, Won Ki Kang, Sun Young Rha, Minkyu Jung, Jin-Soo Kim, Byung Woog Kang, Kyung-Hee Lee, Sang-Young Rho, Jung Han Kim, Kab Choong Kim, Ji Woong Cho, Dae Ro Choi, Hyun Lim, Ho Suk Kang, Ja
      Gastric Cancer.2018; 21(5): 802.     CrossRef
    • Psychiatric comorbidities among ovarian cancer survivors in South Korea: A nationwide population‐based, longitudinal study
      Jaesung Heo, Mison Chun, Young‐Taek Oh, O. Kyu Noh, Logyoung Kim
      Psycho-Oncology.2018; 27(3): 1021.     CrossRef
    • Sequential spinal and intracranial dural metastases in gastric adenocarcinoma: A case report
      Hongsik Kim, Kyung Sik Yi, Won-Dong Kim, Seung-Myoung Son, Yaewon Yang, Jihyun Kwon, Hye Sook Han
      World Journal of Gastroenterology.2018; 24(5): 651.     CrossRef
    • Analysis of Motion-dependent Clinical Outcome of Tumor Tracking Stereotactic Body Radiotherapy for Prostate Cancer
      Hoon Sik Choi, Ki Mun Kang, Bae Kwon Jeong, Jin Ho Song, Yun Hee Lee, In Bong Ha, Sung Chul Kam, Jeong Seok Hwa, Jae Seog Hyun, Jungmo Do, Dong Hyeok Jeong, Hojin Jeong
      Journal of Korean Medical Science.2018;[Epub]     CrossRef
    • Left-Sided Colectomy: One of the Important Risk Factors of Metachronous Colorectal Adenoma After Colectomy for Colon Cancer
      Gee Young Yun, Hee Seok Moon, In Sun Kwon, Ju Seok Kim, Sun Hyung Kang, Eaum Seok Lee, Seok Hyun Kim, Jae Kyu Sung, Byung Seok Lee, Hyun Yong Jeong
      Digestive Diseases and Sciences.2018; 63(4): 1052.     CrossRef
    • A national survey of lung cancer specialists’ views on low-dose CT screening for lung cancer in Korea
      Dong Wook Shin, Sohyun Chun, Young Il Kim, Seung Joon Kim, Jung Soo Kim, SeMin Chong, Young Sik Park, Sang-Yun Song, Jin Han Lee, Hee Kyung Ahn, Eun Young Kim, Sei Hoon Yang, Myoung Kyu Lee, Deog Gon Cho, Tae Won Jang, Ji Woong Son, Jeong-Seon Ryu, Moon-J
      PLOS ONE.2018; 13(2): e0192626.     CrossRef
    • The prevalence and clinical significance of postgastrectomy anemia in patients with early-stage gastric cancer: A retrospective cohort study
      Ji-Hyun Kim, You-Jin Bae, Kyong-Hwa Jun, Hyung-Min Chin
      International Journal of Surgery.2018; 52: 61.     CrossRef
    • Budget Impact of the Accreditation Program for Clinical Laboratories on Colorectal Cancer Screening via Fecal Immunochemical Testing: Results from the National Cancer Screening Program in Korea
      Jae Kwan Jun, Na Young Sung, Seung Hoon Song, Seri Hong, Mi-Ae Jang, Junghan Song, Jeong-Ho Kim, Won-Ki Min, You Kyoung Lee
      Annals of Laboratory Medicine.2018; 38(3): 249.     CrossRef
    • Galanin is an epigenetically silenced tumor suppressor gene in gastric cancer cells
      Daseul Yoon, Kieun Bae, Min-Kyeong Lee, Jin Hee Kim, Kyong-Ah Yoon, Hiromu Suzuki
      PLOS ONE.2018; 13(2): e0193275.     CrossRef
    • The Correlation Between Serum Chemokines and Clinical Outcome in Patients with Advanced Biliary Tract Cancer
      Su Jin Lee, Jung Eun Kim, Seung Tae Kim, Jeeyun Lee, Se Hoon Park, Joon Oh Park, Won Ki Kang, Young Suk Park, Ho Yeong Lim
      Translational Oncology.2018; 11(2): 353.     CrossRef
    • Use of complementary and alternative medicine by lymphoma survivors in South Korea
      Kisook Kim, Soo Hyun Kim, Oh Nam Ok, Im-Ryung Kim, Suyeon Lee, So Hee Kim, Won Seog Kim, Min-Hee Ryu, Moon Hee Lee
      European Journal of Oncology Nursing.2018; 33: 91.     CrossRef
    • Forty‐nine gastric cancer cell lines with integrative genomic profiling for development of c‐MET inhibitor
      Hyun Jeong Kim, Sun Kyoung Kang, Woo Sun Kwon, Tae Soo Kim, Inhye Jeong, Hei‐Cheul Jeung, Michael Kragh, Ivan D. Horak, Hyun Cheol Chung, Sun Young Rha
      International Journal of Cancer.2018; 143(1): 151.     CrossRef
    • Pre-treatment anxiety is associated with persistent chemotherapy-induced peripheral neuropathy in women treated with neoadjuvant chemotherapy for breast cancer
      Kwang-Min Lee, Dooyoung Jung, Heesung Hwang, Kyung-Lak Son, Tae-Yong Kim, Seock-Ah Im, Kyung-Hun Lee, Bong-Jin Hahm
      Journal of Psychosomatic Research.2018; 108: 14.     CrossRef
    • Comparison of the short-term outcomes of reduced-port laparoscopic surgery and conventional multiport surgery in colon cancer: a propensity score matching analysis
      Ji Hoon Kang, Soo Young Lee, Chang Hyun Kim, Hyeong Rok Kim, Han Deok Kwak, Jae Kyun Ju, Young Jin Kim
      Annals of Surgical Treatment and Research.2018; 94(3): 147.     CrossRef
    • Risk of Interval Cancer in Fecal Immunochemical Test Screening Significantly Higher During the Summer Months: Results from the National Cancer Screening Program in Korea
      Jae Myung Cha, Mina Suh, Min Seob Kwak, Na Young Sung, Kui Son Choi, Boyoung Park, Jae Kwan Jun, Sang-Hyun Hwang, Do-Hoon Lee, Byung Chang Kim, You Kyoung Lee, Dong Soo Han
      American Journal of Gastroenterology.2018; 113(4): 611.     CrossRef
    • Kidney transplantation in patients with diabetes: better than nothing
      Chang Seong Kim
      The Korean Journal of Internal Medicine.2018; 33(2): 293.     CrossRef
    • Afatinib in heavily pretreated advanced NSCLC patients who progressed following prior gefitinib or erlotinib: Compassionate use program in Korea
      Moon Ki Choi, Jin Seok Ahn, Young-Chul Kim, Byoung Chul Cho, In-Jae Oh, Sang-We Kim, Jong Seok Lee, Joo-Hang Kim, Myung-Ju Ahn, Keunchil Park
      Lung Cancer.2018; 119: 36.     CrossRef
    • Health-Related Quality of Life in Non-Hodgkin Lymphoma Survivors: A Prospective Cohort Study
      Danbee Kang, Juhee Cho, Im Ryung Kim, Mi Kyung Kim, Won Seog Kim, Seok Jin Kim
      Cancer Research and Treatment.2018; 50(4): 1051.     CrossRef
    • The Prognostic Impact of the Number of Metastatic Lymph Nodes and a New Prognostic Scoring System for Recurrence in Early-Stage Cervical Cancer with High Risk Factors: A Multicenter Cohort Study (KROG 15-04)
      Jeanny Kwon, Keun-Young Eom, Young Seok Kim, Won Park, Mison Chun, Jihae Lee, Yong Bae Kim, Won Sup Yoon, Jin Hee Kim, Jin Hwa Choi, Sei Kyung Chang, Bae Kwon Jeong, Seok Ho Lee, Jihye Cha
      Cancer Research and Treatment.2018; 50(3): 964.     CrossRef
    • Comparative analysis of Adam33 mutations in murine lung cancer cell lines by droplet digital PCR, real-time PCR and Insight Onco™ NGS
      Soo-Jin Kim, Eunhee Kim, Kyung-Taek Rim
      Molecular & Cellular Toxicology.2018; 14(2): 221.     CrossRef
    • Predictive Nomogram for Recurrence of Stage I Colorectal Cancer After Curative Resection
      Chan Kim, Woo Ram Kim, Ki-Yeol Kim, Hong Jae Chon, Seung Hoon Beom, Hyojoong Kim, Minkyu Jung, Sang Joon Shin, Nam Kyu Kim, Joong Bae Ahn
      Clinical Colorectal Cancer.2018; 17(3): e513.     CrossRef
    • Breast Cancer Epidemiology of the Working-Age Female Population Reveals Significant Implications for the South Korean Economy
      Jeong Hyun Park, Se Kyung Lee, Jeong Eon Lee, Seok Won Kim, Seok Jin Nam, Ji-Yeon Kim, Jin-Seok Ahn, Won Park, Jonghan Yu, Yeon Hee Park
      Journal of Breast Cancer.2018; 21(1): 91.     CrossRef
    • Successful Robotic Gastrectomy Does Not Require Extensive Laparoscopic Experience
      Ji Yeong An, Su Mi Kim, Soohyun Ahn, Min-Gew Choi, Jun-Ho Lee, Tae Sung Sohn, Jae-Moon Bae, Sung Kim
      Journal of Gastric Cancer.2018; 18(1): 90.     CrossRef
    • Nab-paclitaxel plus gemcitabine versus FOLFIRINOX as the first-line chemotherapy for patients with metastatic pancreatic cancer: retrospective analysis
      Jihoon Kang, Inhwan Hwang, Changhoon Yoo, Kyu-pyo Kim, Jae Ho Jeong, Heung-Moon Chang, Sang Soo Lee, Do Hyun Park, Tae Jun Song, Dong Wan Seo, Sung Koo Lee, Myung-Hwan Kim, Seung-Mo Hong, Sang Hyun Shin, Dae Wook Hwang, Ki Byung Song, Jae Hoon Lee, Song C
      Investigational New Drugs.2018; 36(4): 732.     CrossRef
    • The combination of cisplatin and topotecan as a second-line treatment for patients with advanced/recurrent uterine cervix cancer
      Ji Young Moon, Ik-Chan Song, Young Bok Ko, Hyo Jin Lee
      Medicine.2018; 97(14): e0340.     CrossRef
    • Higher satisfaction with an alternative collection device for stool sampling in colorectal cancer screening with fecal immunochemical test: a cross-sectional study
      Hye Young Shin, Mina Suh, Kui Son Choi, Sang-Hyun Hwang, Jae Kwan Jun, Dong Soo Han, You Kyoung Lee, Jae Hwan Oh, Chan Wha Lee, Do-Hoon Lee
      BMC Cancer.2018;[Epub]     CrossRef
    • Anaplastic lymphoma kinase (ALK)-expressing Lung Adenocarcinoma with Combined Neuroendocrine Component or Neuroendocrine Transformation: Implications for Neuroendocrine Transformation and Response to ALK-tyrosine Kinase Inhibitors
      Jongmin Sim, Hyunjin Kim, Jiyeon Hyeon, Yoon-La Choi, Joungho Han
      Journal of Korean Medical Science.2018;[Epub]     CrossRef
    • Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2015
      Kyu-Won Jung, Young-Joo Won, Hyun-Joo Kong, Eun Sook Lee
      Cancer Research and Treatment.2018; 50(2): 303.     CrossRef
    • Prediction of Cancer Incidence and Mortality in Korea, 2018
      Kyu-Won Jung, Young-Joo Won, Hyun-Joo Kong, Eun Sook Lee
      Cancer Research and Treatment.2018; 50(2): 317.     CrossRef
    • Intracranial control and survival outcome of tyrosine kinase inhibitor (TKI) alone versus TKI plus radiotherapy for brain metastasis of epidermal growth factor receptor-mutant non-small cell lung cancer
      SooYoon Sung, Sea-Won Lee, Yoo-Kang Kwak, Jin Hyung Kang, Sook Hee Hong, Yeon-Sil Kim
      Journal of Neuro-Oncology.2018; 139(1): 205.     CrossRef
    • Role of Laparoscopic Gastrectomy in Very Elderly Patients with Gastric Cancer Who Have Outlived the Average Lifespan
      Dong Jin Kim, Wook Kim
      Journal of Gastric Cancer.2018; 18(2): 109.     CrossRef
    • Combinatory RNA-Sequencing Analyses Reveal a Dual Mode of Gene Regulation by ADAR1 in Gastric Cancer
      Charles J. Cho, Jaeeun Jung, Lushang Jiang, Eun Ji Lee, Dae-Soo Kim, Byung Sik Kim, Hee Sung Kim, Hwoon-Yong Jung, Ho-June Song, Sung Wook Hwang, Yangsoon Park, Min Kyo Jung, Chan Gi Pack, Seung-Jae Myung, Suhwan Chang
      Digestive Diseases and Sciences.2018; 63(7): 1835.     CrossRef
    • The Incidence of Other Primary Cancers in Patients with Cutaneous Lymphoma
      Young Jae Kim, Ho Jeong Shin, Chong Hyun Won, Sung Eun Chang, Mi Woo Lee, Jee Ho Choi, Woo Jin Lee
      Annals of Dermatology.2018; 30(3): 335.     CrossRef
    • Effects of Heated-Humidified Anesthetic Gas in the Elderly Patients with Colorectal Cancer during Laparoscopic Surgery: Randomized Controlled Trial
      Hyo-Sun Park, Younhee Kang
      Korean Journal of Adult Nursing.2018; 30(2): 206.     CrossRef
    • Feasibility and accessibility of electronic patient-reported outcome measures using a smartphone during routine chemotherapy: a pilot study
      Woo Kyun Bae, Jihyun Kwon, Hyun Woo Lee, Sang-Cheol Lee, Eun-Kee Song, Hyeok Shim, Keun Ho Ryu, Jemin Song, Sungbo Seo, Yaewon Yang, Jong-Hyock Park, Ki Hyeong Lee, Hye Sook Han
      Supportive Care in Cancer.2018; 26(11): 3721.     CrossRef
    • Proposal for cervical cancer screening in the era of HPV vaccination
      Yung-Taek Ouh, Jae Kwan Lee
      Obstetrics & Gynecology Science.2018; 61(3): 298.     CrossRef
    • Updates on Cancer Epidemiology in Korea, 2018
      Sun-Seog Kweon
      Chonnam Medical Journal.2018; 54(2): 90.     CrossRef
    • Changes in ovarian cancer survival during the 20 years before the era of targeted therapy
      Jung-Yun Lee, Sunghoon Kim, Young Tae Kim, Myong Cheol Lim, Boram Lee, Kyu-Won Jung, Jae Weon Kim, Sang-Yoon Park, Young-Joo Won
      BMC Cancer.2018;[Epub]     CrossRef
    • Factors related to cancer screening behaviors
      Boyoung Choi, Tae Rim Um, Kwang-Soo Lee
      Epidemiology and Health.2018; 40: e2018011.     CrossRef
    • Screening Upper Endoscopy for Early Detection of Gastric Cancer
      Jeong Seop Moon
      Journal of Korean Medical Science.2018;[Epub]     CrossRef
    • Risk of second primary Cancer among bladder Cancer patients: a population-based cohort study in Korea
      Whi-An Kwon, Jae Young Joung, Jiwon Lim, Chang-Mo Oh, Kyu-Won Jung, Sung Han Kim, Ho Kyung Seo, Weon Seo Park, Jinsoo Chung, Kang Hyun Lee, Young-Joo Won
      BMC Cancer.2018;[Epub]     CrossRef
    • Effect of mammography screening on stage at breast cancer diagnosis: results from the Korea National Cancer Screening Program
      Kui Son Choi, Minjoo Yoon, Seung Hoon Song, Mina Suh, Boyoung Park, Kyu Won Jung, Jae Kwan Jun
      Scientific Reports.2018;[Epub]     CrossRef
    • Significance of serum ferritin as a prognostic factor in advanced hepatobiliary cancer patients treated with Korean medicine: a retrospective cohort study
      Anna Song, Wankyu Eo, Sehyun Kim, Bumsang Shim, Sookyung Lee
      BMC Complementary and Alternative Medicine.2018;[Epub]     CrossRef
    • Treatment patterns and outcomes in patients with metastatic gastric cancer receiving third-line chemotherapy: A population-based outcomes study
      In Sil Choi, Mihong Choi, Ju Hyun Lee, Jee Hyun Kim, Koung Jin Suh, Ji Yun Lee, Beodeul Kang, Ji-Won Kim, Se-Hyun Kim, Jin Won Kim, Jeong-Ok Lee, Yu Jung Kim, Soo-Mee Bang, Jong Seok Lee, Keun-Wook Lee, Ju-Seog Lee
      PLOS ONE.2018; 13(6): e0198544.     CrossRef
    • A Case of Synchronous Lung Squamous Cell Carcinoma and Diffuse Large B-cell Lymphoma
      Seung Jae Lee, Si Young Lim, Tae Kyung Yoo, Seul Ki Kim, You Gyung Kim, Hyun Joo Lee, Jae Uk Song
      The Korean Journal of Medicine.2018; 93(3): 300.     CrossRef
    • Trends in incidence and survival of esophageal cancer in Korea: Analysis of the Korea Central Cancer Registry Database
      Aesun Shin, Young‐Joo Won, Hye‐Kyung Jung, Hyun‐Joo Kong, Kyu‐Won Jung, Chang‐Mo Oh, Sunho Choe, Jihyun Lee
      Journal of Gastroenterology and Hepatology.2018; 33(12): 1961.     CrossRef
    • Radiological Report of Pilot Study for the Korean Lung Cancer Screening (K-LUCAS) Project: Feasibility of Implementing Lung Imaging Reporting and Data System
      Ji Won Lee, Hyae Young Kim, Jin Mo Goo, Eun Young Kim, Soo Jung Lee, Tae Jung Kim, Yeol Kim, Juntae Lim
      Korean Journal of Radiology.2018; 19(4): 803.     CrossRef
    • A Randomized Phase 2 Trial of Consolidation Chemotherapy After Preoperative Chemoradiation Therapy Versus Chemoradiation Therapy Alone for Locally Advanced Rectal Cancer: KCSG CO 14-03
      Sun Young Kim, Jungnam Joo, Tae Won Kim, Yong Sang Hong, Jeong Eun Kim, In Gyu Hwang, Beom Gyu Kim, Keun-Wook Lee, Ji-Won Kim, Ho-Suk Oh, Joong Bae Ahn, Dae Young Zang, Dae Yong Kim, Jae Hwan Oh, Ji Yeon Baek
      International Journal of Radiation Oncology*Biology*Physics.2018; 101(4): 889.     CrossRef
    • The influence of diabetes and antidiabetic medications on the risk of pancreatic cancer: a nationwide population-based study in Korea
      Da Young Lee, Ji Hee Yu, Sanghyun Park, Kyungdo Han, Nam Hoon Kim, Hye Jin Yoo, Kyung Mook Choi, Sei Hyun Baik, Nan Hee Kim, Ji A. Seo
      Scientific Reports.2018;[Epub]     CrossRef
    • Status of BRCA1/2 Genetic Testing Practices in Korea (2014)
      Kyungju Lee, Ja-Hyun Jang, Seung-Tae Lee, Kyong-Ah Yoon, Eun Sook Lee, Jong-Won Kim, Sun-Young Kong
      Laboratory Medicine Online.2018; 8(3): 107.     CrossRef
    • How Should Biobanks Collect Biosamples for Clinical Application? A 20-year Biomarker-related Publication and Patent Trend Analysis
      Jae-Eun Lee
      Osong Public Health and Research Perspectives.2018; 9(3): 105.     CrossRef
    • External validation of IBTR! 2.0 nomogram for prediction of ipsilateral breast tumor recurrence
      Byung Min Lee, Jee Suk Chang, Young Up Cho, Seho Park, Hyung Seok Park, Jee Ye Kim, Joo Hyuk Sohn, Gun Min Kim, Ja Seung Koo, Ki Chang Keum, Chang-Ok Suh, Yong Bae Kim
      Radiation Oncology Journal.2018; 36(2): 139.     CrossRef
    • Survival Trends in Gastric Adenocarcinoma: A Population-Based Study in Sweden
      Johannes Asplund, Joonas H. Kauppila, Fredrik Mattsson, Jesper Lagergren
      Annals of Surgical Oncology.2018; 25(9): 2693.     CrossRef
    • A comparative study of the clinical characteristics of breast cancer patients less than 35 years old and older patients
      Tae Sik Hwang, Ah Rem Jeong, Joung Won Na, Yun Yeong Kim, Joon-Hyop Lee, Yoo Seung Chung, Sang Tae Choi, Jin Mo Kang, Heung Kyu Park, Yong Soon Chun
      Korean Journal of Clinical Oncology.2018; 14(1): 1.     CrossRef
    • Metastatic colon cancer of an ovarian cancer origin mimicking primary colon cancer: A case report
      Ji-Hyeon Park, Dong Hae Jung, Jeong-Heum Baek
      Korean Journal of Clinical Oncology.2018; 14(1): 53.     CrossRef
    • Relationships among Mood Status, Social Support, Symptom Experience and Quality of Life in Colorectal Cancer Patients - based on the Theory of Unpleasant Symptoms
      Hyun Jeong Seo, Eun Jung Ryu, Mi Young Ham
      Asian Oncology Nursing.2018; 18(2): 104.     CrossRef
    • Long-Term Clinical Outcomes of Endoscopic Submucosal Dissection in Patients with Early Gastric Cancer: A Prospective Multicenter Cohort Study
      Sang Gyun Kim, Chan Mi Park, Na Rae Lee, Jiyoung Kim, Da Hyun Lyu, Seung-Hee Park, Il Ju Choi, Wan Sik Lee, Seun Ja Park, Jae Jun Kim, Ji Hyun Kim, Chul-Hyun Lim, Joo Young Cho, Gwang Ha Kim, Yong Chan Lee, Hwoon-Yong Jung, Jun Haeng Lee, Hoon Jai Chun, S
      Gut and Liver.2018; 12(4): 402.     CrossRef
    • Apoptotic and antiproliferative effects of Stigmast-5-en-3-ol from Dendronephthya gigantea on human leukemia HL-60 and human breast cancer MCF-7 cells
      I.P. Shanura Fernando, K.K. Asanka Sanjeewa, Yong-Seok Ann, Chang-ik Ko, Seung-Hong Lee, Won Woo Lee, You-Jin Jeon
      Toxicology in Vitro.2018; 52: 297.     CrossRef
    • Necessity of adjuvant concurrent chemo-radiotherapy in D2-resected LN-positive gastric cancer
      Jeong Il Yu, Do Hoon Lim, Jeeyun Lee, Won Ki Kang, Se Hoon Park, Joon Oh Park, Young Suk Park, Ho Yeong Lim, Seung Tae Kim, Su Jin Lee, Sung Kim, Tae Sung Sohn, Jun Ho Lee, Ji Yeong An, Min Gew Choi, Jae Moon Bae, Hye Seung Kim, Soohyun Ahn
      Radiotherapy and Oncology.2018; 129(2): 306.     CrossRef
    • Decreasing Disease-Specific Mortality of Differentiated Thyroid Cancer in Korea: A Multicenter Cohort Study
      Min Ji Jeon, Hee Kyung Kim, Eun Heui Kim, Eun Sook Kim, Hyon-Seung Yi, Tae Yong Kim, Ho-Cheol Kang, Young Kee Shong, Won Bae Kim, Bo Hyun Kim, Won Gu Kim
      Thyroid.2018; 28(9): 1121.     CrossRef
    • Marked Loss of Muscle, Visceral Fat, or Subcutaneous Fat After Gastrectomy Predicts Poor Survival in Advanced Gastric Cancer: Single-Center Study from the CLASSIC Trial
      Hyung Soon Park, Hyo Song Kim, Seung Hoon Beom, Sun Young Rha, Hyun Cheol Chung, Jee Hung Kim, You Jin Chun, Si Won Lee, Eun-Ah Choe, Su Jin Heo, Sung Hoon Noh, Woo Jin Hyung, Jae-Ho Cheong, Hyoung-Il Kim, Taeil Son, Joon Seok Lim, Song-Ee Baek, Minkyu Ju
      Annals of Surgical Oncology.2018; 25(11): 3222.     CrossRef
    • Association Between Fusobacterium nucleatum, Pathway Mutation, and Patient Prognosis in Colorectal Cancer
      Dae-Won Lee, Sae-Won Han, Jun-Kyu Kang, Jeong Mo Bae, Hwang-Phill Kim, Jae-Kyung Won, Seung-Yong Jeong, Kyu Joo Park, Gyeong Hoon Kang, Tae-You Kim
      Annals of Surgical Oncology.2018; 25(11): 3389.     CrossRef
    • Adjuvant Chemotherapy Versus Chemoradiation for Patients with Resected Pancreatic Adenocarcinoma: A Single-Center Retrospective Study
      Do Young Kim, Young Jin Choi, Young Mi Seol, Hyojeong Kim
      The Korean Journal of Pancreas and Biliary Tract.2018; 23(3): 108.     CrossRef
    • Researches of Epigenetic Epidemiology for Infections and Radiation as Carcinogen
      Jong-Myon Bae
      Journal of Preventive Medicine and Public Health.2018; 51(4): 169.     CrossRef
    • Disparities in Cervical Cancer Screening Among Women With Disabilities: A National Database Study in South Korea
      Dong Wook Shin, Jeong-Won Lee, Jin Hyung Jung, Kyungdo Han, So Young Kim, Kui Son Choi, Jong Heon Park, Jong Hyock Park
      Journal of Clinical Oncology.2018; 36(27): 2778.     CrossRef
    • Real-world treatment patterns for patients 80 years and older with early lung cancer: a nationwide claims study
      Kyungjong Lee, Hye Ok Kim, Hee Kyoung Choi, Gi Hyeon Seo
      BMC Pulmonary Medicine.2018;[Epub]     CrossRef
    • Novel graded prognostic assessment for colorectal cancer patients with brain metastases
      Byoung Hyuck Kim, Hae Jin Park, Kyubo Kim, Sae-Won Han, Tae-You Kim, Seung-Yong Jeong, Kyu Joo Park, Eui Kyu Chie
      International Journal of Clinical Oncology.2018; 23(6): 1112.     CrossRef
    • BRCA1/2 mutations, including large genomic rearrangements, among unselected ovarian cancer patients in Korea
      Do-Hoon Kim, Chi-Heum Cho, Sun Young Kwon, Nam-Hee Ryoo, Dong-Seok Jeon, Wonmok Lee, Jung-Sook Ha
      Journal of Gynecologic Oncology.2018;[Epub]     CrossRef
    • Three-Port Right-Side Approach-Duet Totally Laparoscopic Distal Gastrectomy for Uncut Roux-en-Y Reconstruction
      Ho Seok Seo, Yoon Ju Jung, Ji Hyun Kim, Cho Hyun Park, Han Hong Lee
      Journal of Laparoendoscopic & Advanced Surgical Techniques.2018; 28(9): 1109.     CrossRef
    • Preoperative Nodal 18F-FDG Avidity Rather than Primary Tumor Avidity Determines the Prognosis of Patients with Advanced Gastric Cancer
      Hyun Woo Kwon, Liang An, Hye Ryeong Kwon, Sungsoo Park, Sungeun Kim
      Journal of Gastric Cancer.2018; 18(3): 218.     CrossRef
    • Comparison of cervical cancer screening among women with and without hysterectomies: a nationwide population-based study in Korea
      Ji-Yeon Shin, Kui Son Choi, Mina Suh, Boyoung Park, Jae Kwan Jun
      BMC Cancer.2018;[Epub]     CrossRef
    • Establishment and Characterization of Paired Primary and Peritoneal Seeding Human Colorectal Cancer Cell Lines: Identification of Genes That Mediate Metastatic Potential
      Soon-Chan Kim, Chang-Won Hong, Sang-Geun Jang, Ye-Ah Kim, Byong-Chul Yoo, Young-Kyoung Shin, Seung-Yong Jeong, Ja-Lok Ku, Jae-Gahb Park
      Translational Oncology.2018; 11(5): 1232.     CrossRef
    • Association between the Dietary Inflammatory Index and Risk for Cancer Recurrence and Mortality among Patients with Breast Cancer
      Hyeonjeong Jang, Min Sung Chung, Shin Sook Kang, Yongsoon Park
      Nutrients.2018; 10(8): 1095.     CrossRef
    • Breast Ultrasound Computer-Aided Diagnosis: Analysis of Types of Errors
      Min Kyung Jeong, Bong Joo Kang, Eunjeong Kim, Sung Hun Kim
      Journal of the Korean Society of Radiology.2018; 79(3): 114.     CrossRef
    • Nurse-led interventions on quality of life for patients with cancer
      Xiuju Cheng, Shougang Wei, Huapeng Zhang, Senyao Xue, Wei Wang, Kaikai Zhang
      Medicine.2018; 97(34): e12037.     CrossRef
    • Prevalence and risk factors for upper gastrointestinal diseases in health check-up subjects: a nationwide multicenter study in Korea
      Kwangwoo Nam, Jeong Eun Shin, Sung Eun Kim, Gwang Ho Baik, Sang Hyeon Choi, Ju Yup Lee, Kyung Sik Park, Young-Eun Joo, Dae-Seong Myung, Hyeon Ju Kim, Hyun Joo Song, Suck Chei Choi, Hyun Jin Kim, Hyun Young Kim, Nayoung Kim
      Scandinavian Journal of Gastroenterology.2018; 53(8): 910.     CrossRef
    • Lymphovascular Invasion Increases the Risk of Nodal and Distant Recurrence in Node-Negative Stage I–IIA Non-Small-Cell Lung Cancer
      Soo Yoon Sung, Yoo-Kang Kwak, Sea-Won Lee, In Young Jo, Jae Kil Park, Kyung Soo Kim, Kyo Young Lee, Yeon-Sil Kim
      Oncology.2018; 95(3): 156.     CrossRef
    • Colonoscopy education for surgical residents in Korea: a national survey of Korean Surgical Skill Study Group
      Duck-Woo Kim, Min Hyun Kim, Hyun Ae Kim, Kil Yeon Lee, Seung-Yong Jeong, Woo Yong Lee
      Annals of Surgical Treatment and Research.2018; 95(3): 121.     CrossRef
    • Socioeconomic Inequalities in Stomach Cancer Screening in Korea, 2005–2015: After the Introduction of the National Cancer Screening Program
      Eun-young Lee, Yoon Young Lee, Mina Suh, Eunji Choi, Tran Thi Xuan Mai, Hyunsoon Cho, Boyoung Park, Jae Kwan Jun, Yeol Kim, Jin Kyung Oh, Moran Ki, Kui Son Choi
      Yonsei Medical Journal.2018; 59(8): 923.     CrossRef
    • Evaluation of various kinetic parameters of CA-125 in patients with advanced-stage ovarian cancer undergoing neoadjuvant chemotherapy
      Yong Jae Lee, In Ha Lee, Yun-Ji Kim, Young Shin Chung, Jung-Yun Lee, Eun Ji Nam, Sunghoon Kim, Sang Wun Kim, Young Tae Kim, Surinder K. Batra
      PLOS ONE.2018; 13(9): e0203366.     CrossRef
    • Clinical Significance of Circulating Tumor Cells in Gastric Cancer
      Hye Kyung Jeon, Gwang Ha Kim
      The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2018; 18(3): 162.     CrossRef
    • Noncontrast magnetic resonance imaging versus ultrasonography for hepatocellular carcinoma surveillance (MIRACLE-HCC): study protocol for a prospective randomized trial
      Chansik An, Do Young Kim, Jin-Young Choi, Kwang Hyub Han, Yun Ho Roh, Myeong-Jin Kim
      BMC Cancer.2018;[Epub]     CrossRef
    • Factors Affecting Endoscopic Curative Resection of Gastric Cancer in the Population-Based Screening Era
      Yoon Gwon Mun, Myung-Gyu Choi, Chul-Hyun Lim, Han Hee Lee, Dong Hoon Kang, Jae Myung Park, Kyo Young Song
      Clinical Endoscopy.2018; 51(5): 478.     CrossRef
    • The role of third-line chemotherapy in recurrent or metastatic gastric cancer
      Yong Won Choi, Mi Sun Ahn, Geum Sook Jeong, Hyun Woo Lee, Seong Hyun Jeong, Seok Yun Kang, Joon Seong Park, Jin-Hyuk Choi, Seung Soo Sheen
      Medicine.2018; 97(39): e12588.     CrossRef
    • Primary malignant peripheral nerve sheath tumor of prostate in a young adult
      Hyojeong Kim, Do Young Kim, Young Mi Seol, Ja Yoon Ku, Kyung Un Choi, Young Jin Choi
      Medicine.2018; 97(39): e12040.     CrossRef
    • BRCA1/2-negative, high-risk breast cancers (BRCAX) for Asian women: genetic susceptibility loci and their potential impacts
      Joo-Yeon Lee, Jisun Kim, Sung-Won Kim, Sue K. Park, Sei Hyun Ahn, Min Hyuk Lee, Young Jin Suh, Dong-Young Noh, Byung Ho Son, Young Up Cho, Sae Byul Lee, Jong Won Lee, John L. Hopper, Joohon Sung
      Scientific Reports.2018;[Epub]     CrossRef
    • Effect of Smoking Cessation and Reduction on the Risk of Cancer in Korean Men: A Population Based Study
      Seulggie Choi, Jooyoung Chang, Kyuwoong Kim, Sang Min Park, Kiheon Lee
      Cancer Research and Treatment.2018; 50(4): 1114.     CrossRef
    • Trends in Gastric Cancer Incidence According to the Clinicopathological Characteristics in Korea, 1999-2014
      Bang Wool Eom, Kyu-Won Jung, Young-Joo Won, Hannah Yang, Young-Woo Kim
      Cancer Research and Treatment.2018; 50(4): 1343.     CrossRef
    • Phase II Study of Dovitinib in Patients with Castration-Resistant Prostate Cancer (KCSG-GU11-05)
      Yoon Ji Choi, Hye Sook Kim, Se Hoon Park, Bong-Seog Kim, Kyoung Ha Kim, Hyo Jin Lee, Hong Suk Song, Dong-Yeop Shin, Ha Young Lee, Hoon-Gu Kim, Kyung Hee Lee, Jae Lyun Lee, Kyong Hwa Park
      Cancer Research and Treatment.2018; 50(4): 1252.     CrossRef
    • Socioeconomic Inequalities in Cervical and Breast Cancer Screening among Women in Korea, 2005–2015
      Eunji Choi, Yoon Young Lee, Mina Suh, Eun Young Lee, Tran Thi Xuan Mai, Moran Ki, Jin-Kyoung Oh, Hyunsoon Cho, Boyoung Park, Jae Kwan Jun, Yeol Kim, Kui Son Choi
      Yonsei Medical Journal.2018; 59(9): 1026.     CrossRef
    • Socioeconomic Inequalities in Colorectal Cancer Screening in Korea, 2005–2015: After the Introduction of the National Cancer Screening Program
      Tran Thi Xuan Mai, Yoon Young Lee, Mina Suh, Eunji Choi, Eun Young Lee, Moran Ki, Hyunsoon Cho, Boyoung Park, Jae Kwan Jun, Yeol Kim, Jin-Kyoung Oh, Kui Son Choi
      Yonsei Medical Journal.2018; 59(9): 1034.     CrossRef
    • Acupuncture for the Treatment of Taxane‐Induced Peripheral Neuropathy in Breast Cancer Patients: A Pilot Trial
      Young Ju Jeong, Min Ah Kwak, Jung Chul Seo, Seong Hoon Park, Jin Gu Bong, Im Hee Shin, Sung Hwan Park, Sven Schröder
      Evidence-Based Complementary and Alternative Medicine.2018;[Epub]     CrossRef
    • Eighth edition of tumor-node-metastasis staging system improve survival predictability for papillary, but not follicular thyroid carcinoma: A multicenter cohort study
      Mijin Kim, Hye In Kim, Min Ji Jeon, Hee Kyung Kim, Eun Heui Kim, Hyon-Seung Yi, Eun Sook Kim, Hosu Kim, Bo Hyun Kim, Tae Yong Kim, Sun Wook Kim, Ho-Cheol Kang, Won Bae Kim, Jae Hoon Chung, Young Kee Shong, Tae Hyuk Kim, Won Gu Kim
      Oral Oncology.2018; 87: 97.     CrossRef
    • Occupational cancer claims in Korea from 2010 to 2016
      Kyungjoon Lee, Sujin Lee, Jeehee Min, Inah Kim
      Annals of Occupational and Environmental Medicine.2018;[Epub]     CrossRef
    • Rate and Structure of Mortality from Malignant Neopasms of Lymphatic and Haematopoietic Tissue in the Regions of the Republic of Bashkortostan (2006–2015)
      R. A. Maier, A. F. Baibulatova, B. A. Bakirov
      Creative surgery and oncology.2018; 8(2): 52.     CrossRef
    • Cancer risk after renal transplantation in South Korea: a nationwide population-based study
      Jaesung Heo, O Kyu Noh, Young-Taek Oh, Mison Chun, Logyoung Kim
      BMC Nephrology.2018;[Epub]     CrossRef
    • Risk factors for cytological progression in HPV 16 infected women with ASC-US or LSIL: The Korean HPV cohort
      Kyeong A So, Seon Ah Kim, Yoo Kyung Lee, In Ho Lee, Ki Heon Lee, Jee Eun Rhee, Mee Kyung Kee, Chi Heum Cho, Sung Ran Hong, Chang Sun Hwang, Mi Seon Jeong, Ki Tae Kim, Moran Ki, Soo Young Hur, Jong Sup Park, Tae Jin Kim
      Obstetrics & Gynecology Science.2018; 61(6): 662.     CrossRef
    • Comparison of efficacy and safety between standard-dose and modified-dose FOLFIRINOX as a first-line treatment of pancreatic cancer
      Huapyong Kang, Jung Hyun Jo, Hee Seung Lee, Moon Jae Chung, Seungmin Bang, Seung Woo Park, Si Young Song, Jeong Youp Park
      World Journal of Gastrointestinal Oncology.2018; 10(11): 421.     CrossRef
    • Clinical and Laboratory Characteristics and Mortality in Korean Patients with Systemic Sclerosis: A Nationwide Multicenter Retrospective Cohort Study
      Ki Won Moon, Shin-Seok Lee, Yun Jong Lee, Jae-Bum Jun, Su-Jin Yoo, Ji Hyeon Ju, Sung Hae Chang, In Ah Choi, Tae Young Kang, Eun Bong Lee, Seung-Geun Lee
      The Journal of Rheumatology.2018; 45(9): 1281.     CrossRef
    • Recent treatment patterns and survival outcomes in pancreatic cancer according to clinical stage based on single-center large-cohort data
      Doo-ho Lee, Jin-Young Jang, Jae Seung Kang, Jae Ri Kim, Youngmin Han, Eunjung Kim, Wooil Kwon, Sun-Whe Kim
      Annals of Hepato-Biliary-Pancreatic Surgery.2018; 22(4): 386.     CrossRef
    • Different mutational characteristics of the subsets of EGFR-tyrosine kinase inhibitor sensitizing mutation-positive lung adenocarcinoma
      Eun Young Kim, Arum Kim, Gaeun Lee, Hangsuck Lee, Yoon Soo Chang
      BMC Cancer.2018;[Epub]     CrossRef
    • Efficacy of Intraoperative Neural Monitoring (IONM) in Thyroid Surgery: the Learning Curve
      Min Kyu Kwak, Song Jae Lee, Chang Myeon Song, Yong Bae Ji, Kyung Tae
      International Journal of Thyroidology.2018; 11(2): 130.     CrossRef
    • Evaluation of Surgical Completeness in Endoscopic Total Thyroidectomy with Central Neck Dissection via a Unilateral Axillo-Breast Approach Compared with Bilateral Axillo-Breast and Open Approach
      Ik Joon Choi, Ilhan Lim, Byeong-Cheol Lee, Guk Haeng Lee, Myung-Chul Lee
      Korean Journal of Otorhinolaryngology-Head and Neck Surgery.2018; 61(12): 697.     CrossRef
    • Clinical relevance of Lgr5 expression in colorectal cancer patients
      Young Joo Kim, Dong Hyun Kang, Geum Jong Song, Tae Sung Ahn, Myoung Won Son, Moon Soo Lee, Moo-Jun Baek
      Korean Journal of Clinical Oncology.2018; 14(2): 76.     CrossRef
    • Female Sex and Right-Sided Tumor Location Are Poor Prognostic Factors for Patients With Stage III Colon Cancer After a Curative Resection
      Jung Ho Park, Hyoung-Chul Park, Sung Chan Park, Jae Hwan Oh, Duck-Woo Kim, Sung-Bum Kang, Seung Chul Heo, Min Jung Kim, Ji Won Park, Seung-Yong Jeong, Kyu Joo Park
      Annals of Coloproctology.2018; 34(6): 286.     CrossRef
    • National Epidemiologic Survey of Thyroid cancer (NEST) in Korea
      Chang-Mo Oh, Hyun-Joo Kong, Eunyang Kim, Hyejin Kim, Kyu-Won Jung, Sohee Park, Young-Joo Won
      Epidemiology and Health.2018; 40: e2018052.     CrossRef
    • Somatic Mutations from Whole Exome Sequencing Analysis of the Patients with Biliary Tract Cancer
      Kyong-Ah Yoon, Sang Myung Woo, Yun-Hee Kim, Sun-Young Kong, Sung-Sik Han, Sang-Jae Park, Woo Jin Lee
      Genomics & Informatics.2018; 16(4): e35.     CrossRef
    • Optimal Starting Age for Colorectal Cancer Screening in an Era of Increased Metabolic Unhealthiness: A Nationwide Korean Cross-Sectional Study
      Yoon Jin Choi, Dong Ho Lee, Kyung-Do Han, Hyun Soo Kim, Hyuk Yoon, Cheol Min Shin, Young Soo Park, Nayoung Kim
      Gut and Liver.2018; 12(6): 655.     CrossRef
    • Effects of 17beta;-Estradiol on Colonic Permeability and Inflammation in an Azoxymethane/Dextran Sulfate Sodium-Induced Colitis Mouse Model
      Chin-Hee Song, Nayoung Kim, Sung Hwa Sohn, Sun Min Lee, Ryoung Hee Nam, Hee Young Na, Dong Ho Lee, Young-Joon Surh
      Gut and Liver.2018; 12(6): 682.     CrossRef
    • Risk of Malnutrition after Gastrointestinal Cancer Surgery: A Propensity Score Matched Retrospective Cohort Study
      Sung-Hoon Yoon, Bong-Hyeon Kye, Hyung-Jin Kim, Kyong-Hwa Jun, Hyeon-Min Cho, Hyung-Min Chin
      Surgical Metabolism and Nutrition.2018; 9(1): 16.     CrossRef
    • Validation of Administrative Big Database for Colorectal Cancer Searched by International Classification of Disease 10th Codes in Korean: A Retrospective Big-cohort Study
      Young-Jae Hwang, Nayoung Kim, Chang Yong Yun, Hyuk Yoon, Cheol Min Shin, Young Soo Park, Il Tae Son, Heung-Kwon Oh, Duck-Woo Kim, Sung-Bum Kang, Hye Seung Lee, Seon Mee Park, Dong Ho Lee
      Journal of Cancer Prevention.2018; 23(4): 183.     CrossRef
    • Prognostic Implications of Multiplex Detection of KRAS Mutations in Cell-Free DNA from Patients with Pancreatic Ductal Adenocarcinoma
      Min Kyeong Kim, Sang Myung Woo, Boram Park, Kyong-Ah Yoon, Yun-Hee Kim, Jungnam Joo, Woo Jin Lee, Sung-Sik Han, Sang-Jae Park, Sun-Young Kong
      Clinical Chemistry.2018; 64(4): 726.     CrossRef
    • EGFR mutation decreases FDG uptake in non‑small cell lung cancer via the NOX4/ROS/GLUT1 axis
      Long Chen, Yongchun Zhou, Xiaoxia Tang, Conghui Yang, Yadong Tian, Ran Xie, Ting Chen, Jiapeng Yang, Mingwei Jing, Fukun Chen, Chun Wang, Hua Sun, Yunchao Huang
      International Journal of Oncology.2018;[Epub]     CrossRef
    • Molecular Basis of Alcohol-Related Gastric and Colon Cancer
      Hye-Kyung Na, Ja Lee
      International Journal of Molecular Sciences.2017; 18(6): 1116.     CrossRef
    • Second Primary Cancer Screening: Role of the Primary Care Physician
      Seung-Won Oh
      Korean Journal of Family Medicine.2017; 38(3): 109.     CrossRef
    • Opioid Withdrawal Symptoms after Conversion to Oral Oxycodone/Naloxone in Advanced Cancer Patients Receiving Strong Opioids
      Jung Hoon Kim, Haana Song, Gyeong-Won Lee, Jung Hun Kang
      The Korean Journal of Hospice and Palliative Care.2017; 20(2): 131.     CrossRef
    • Thyroid function after TSH suppression for thyroid cancer: When is optimal time to check?
      Laura Sterian Ward, Danilo Villagelin
      Clinical Endocrinology.2017; 87(3): 231.     CrossRef
    • Validity of self-reported cancer history in the health examinees (HEXA) study: A comparison of self-report and cancer registry records
      Sooyoung Cho, Aesun Shin, Daesub Song, Jae Kyung Park, Yeonjung Kim, Ji-Yeob Choi, Daehee Kang, Jong-Koo Lee
      Cancer Epidemiology.2017; 50: 16.     CrossRef
    • External Validation of a Gastric Cancer Nomogram Derived from a Large-volume Center Using Dataset from a Medium-volume Center
      Pyeong Su Kim, Kyung-Muk Lee, Dong-Seok Han, Moon-Won Yoo, Hye Seung Han, Han-Kwang Yang, Ho Yoon Bang
      Journal of Gastric Cancer.2017; 17(3): 204.     CrossRef
    • Strategies for Appropriate Patient-centered Care to Decrease the Nationwide Cost of Cancers in Korea
      Jong-Myon Bae
      Journal of Preventive Medicine and Public Health.2017; 50(4): 217.     CrossRef
    • Changes in standardized mortality rates from thyroid cancer in Korea between 1985 and 2015: Analysis of Korean national data
      Yun Mi Choi, Won Gu Kim, Hyemi Kwon, Min Ji Jeon, Minkyu Han, Tae Yong Kim, Young Kee Shong, Sang Mo Hong, Eun‐Gyoung Hong, Won Bae Kim
      Cancer.2017; 123(24): 4808.     CrossRef
    • Stress and Depressive Symptoms in Cancer Survivors and Their Family Members: Korea Community Health Survey, 2012
      Mi Han
      International Journal of Environmental Research and Public Health.2017; 14(9): 999.     CrossRef
    • Karyopherin α-2 is a reliable marker for identification of patients with high-risk stage II colorectal cancer
      Dongjun Jeong, Hyeongjoo Kim, Seona Ban, Seunghyun Oh, Sanghee Ji, Doyeon Kim, Tae Sung Ahn, Han Jo Kim, Sang Byung Bae, Hyog Young Kwon, Jungkyun Im, Moon Soo Lee, Hyun Deuk Cho, Chang-Jin Kim, Moo-Jun Baek
      Journal of Cancer Research and Clinical Oncology.2017; 143(12): 2493.     CrossRef
    • Second primary cancer after liver transplantation in hepatocellular carcinoma: a nationwide population-based study
      Jaesung Heo, O. Kyu Noh, Young-Taek Oh, Mison Chun, Logyoung Kim
      Hepatology International.2017; 11(6): 523.     CrossRef
    • Association Between Health Behaviors and Family History of Cancer in Cancer Survivors: Data From the Korean Genome and Epidemiology Study
      Minji Hwang, Boyoung Park
      Journal of Cancer Prevention.2017; 22(3): 166.     CrossRef
    • Insulin Resistance Associated With Differentiated Thyroid Carcinoma: Penalized Conditional Logistic Regression Analysis of a Matched Case-Control Study Data
      Zahra Heidari, Mahdi Abdani, Mohammad Ali Mansournia
      International Journal of Endocrinology and Metabolism.2017;[Epub]     CrossRef
    • Phase II, multicentre, randomised trial of eribulin plus gemcitabine versus paclitaxel plus gemcitabine as first-line chemotherapy in patients with HER2-negative metastatic breast cancer
      Yeon Hee Park, Seock-Ah Im, Sung-Bae Kim, Joo Hyuk Sohn, Keun Seok Lee, Yee Soo Chae, Ki Hyeong Lee, Jee Hyun Kim, Young-Hyuck Im, Ji-Yeon Kim, Tae-Yong Kim, Kyung-Hun Lee, Jin-Hee Ahn, Gun Min Kim, In Hae Park, Soo Jung Lee, Hye Sook Han, Se Hyun Kim, Ky
      European Journal of Cancer.2017; 86: 385.     CrossRef
    • Screening strategy for colorectal cancer according to risk
      Dong Soo Han
      Journal of the Korean Medical Association.2017; 60(11): 893.     CrossRef
    • Active Surveillance of Papillary Thyroid Microcarcinoma: A Mini-Review from Korea
      Tae Yong Kim, Young Kee Shong
      Endocrinology and Metabolism.2017; 32(4): 399.     CrossRef
    • Treatment Patterns and Outcomes in Elderly Patients with Metastatic Breast Cancer: A Multicenter Retrospective Study
      Jin Hyun Park, In Sil Choi, Ki Hwan Kim, Jin-Soo Kim, Kyung-Hun Lee, Tae-Yong Kim, Seock-Ah Im, Se Hyun Kim, Yu Jung Kim, Jee Hyun Kim
      Journal of Breast Cancer.2017; 20(4): 368.     CrossRef
    • Dietary supplement use among cancer survivors and the general population: a nation-wide cross-sectional study
      Sihan Song, Jiyoung Youn, Yun Jung Lee, Minji Kang, Taisun Hyun, YoonJu Song, Jung Eun Lee
      BMC Cancer.2017;[Epub]     CrossRef
    • Gastric Cancer Recurrence in 12 Years after Surgical Resection
      Ki Hwan Ku, Seun Ja Park, Jae Hyun Kim, Hye Jung Kwon, Hee Kyung Chang, Jung Gu Park
      The Korean Journal of Gastroenterology.2017; 70(6): 296.     CrossRef
    • Treatment with Cisplatin and Etoposide Chemotherapy in Patient with Metastatic Breast Cancer
      Mi Kim, Jin-sun Lee
      Journal of Breast Disease.2017; 5(2): 39.     CrossRef
    • Comparison of post-surgery follow-up methods in patients aged 80 years or older with non-metastatic colorectal cancer
      Dong Min Seo, Ji Won Park, Dong Woon Lee, Yoon-Hye Kwon, In Ho Song, Seung-Bum Ryoo, Seung-Yong Jeong, Kyu Joo Park
      Korean Journal of Clinical Oncology.2017; 13(2): 102.     CrossRef
    • Secular Trends for Diagnostic Motives and Environmental Risk Factors in Thyroid Cancer Using Questionnaire Survey
      Hana Kim, Yul Hwangbo, Sung Hye Kong, Young Shin Song, Min Joo Kim, Sun Wook Cho, You Jin Lee, Ka Hee Yi, Do Joon Park, Eun Kyung Lee, Young Joo Park
      International Journal of Thyroidology.2017; 10(2): 82.     CrossRef
    • Clinicopathological impacts of high c-Met expression in head and neck squamous cell carcinoma: a meta-analysis and review
      Jung Han Kim, Bum Jun Kim, Hyeong Su Kim
      Oncotarget.2017; 8(68): 113120.     CrossRef
    • The role of anti-EGFR agents in patients with locoregionally advanced head and neck cancer: a meta-analysis of randomized trials
      Bum Jun Kim, Jae Ho Jeong, Hyeong Su Kim, Jung Han Kim
      Oncotarget.2017; 8(60): 102371.     CrossRef
    • The role of anti-EGFR agents in the first-line treatment of advanced esophago-gastric adenocarcinoma: a meta-analysis
      Bum Jun Kim, Jung Han Kim, Hyun Joo Jang, Hyeong Su Kim
      Oncotarget.2017; 8(58): 99033.     CrossRef
    • Prognostic value of c-Met overexpression in hepatocellular carcinoma: a meta-analysis and review
      Jung Han Kim, Hyeong Su Kim, Bum Jun Kim, Hyun Joo Jang, Jin Lee
      Oncotarget.2017; 8(52): 90351.     CrossRef
    • Clinicopathological impacts of high c-Met expression in renal cell carcinoma: a meta-analysis and review
      Jung Han Kim, Bum Jun Kim, Hyeong Su Kim
      Oncotarget.2017; 8(43): 75478.     CrossRef
    • Molecular targeted agents as second-line treatment for hepatocellular carcinoma: a meta-analysis and review
      Jung Han Kim, Bum Jun Kim, Hyun Joo Jang, Jin Lee
      Oncotarget.2017; 8(60): 102321.     CrossRef
    • Prognostic value of smoking status in non-small-cell lung cancer patients treated with immune checkpoint inhibitors: a meta-analysis
      Jung Han Kim, Hyeong Su Kim, Bum Jun Kim
      Oncotarget.2017; 8(54): 93149.     CrossRef
    • The addition of bevacizumab in the first-line treatment for metastatic colorectal cancer: an updated meta-analysis of randomized trials
      Hyun Joo Jang, Bum Jun Kim, Jung Han Kim, Hyeong Su Kim
      Oncotarget.2017; 8(42): 73009.     CrossRef
    • MET inhibitors in advanced non-small-cell lung cancer: a meta-analysis and review
      Jung Han Kim, Hyeong Su Kim, Bum Jun Kim
      Oncotarget.2017; 8(43): 75500.     CrossRef
    • Survival benefit of anti-angiogenic agents in patients with previously treated advanced gastric or gastroesophageal junction cancer: a meta-analysis
      Jung Han Kim, Hyeong Su Kim, Bum Jun Kim, Hyun Joo Jang
      Oncotarget.2017; 8(57): 97565.     CrossRef
    • Prognostic value of c-Met overexpression in pancreatic adenocarcinoma: a meta-analysis
      Jung Han Kim, Hyeong Su Kim, Bum Jun Kim, Jin Lee, Hyun Joo Jang
      Oncotarget.2017; 8(42): 73098.     CrossRef
    • Korean OBEsity Surgical Treatment Study (KOBESS): protocol of a prospective multicentre cohort study on obese patients undergoing laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass
      Young Suk Park, Do Joong Park, Joo Ho Lee, Hyuk-Joon Lee, Tae Kyung Ha, Yong-Jin Kim, Seung-Wan Ryu, Sang-Moon Han, Moon-Won Yoo, Sungsoo Park, Sang-Uk Han, Yoonseok Heo
      BMJ Open.2017; 7(10): e018044.     CrossRef
    • Occupational radiation exposure and its health effects on interventional medical workers: study protocol for a prospective cohort study
      Seulki Ko, Hwan Hoon Chung, Sung Bum Cho, Young Woo Jin, Kwang Pyo Kim, Mina Ha, Ye Jin Bang, Yae Won Ha, Won Jin Lee
      BMJ Open.2017; 7(12): e018333.     CrossRef
    • N of 1 case reports of exceptional responders accrued from pancreatic cancer patients enrolled in first-in-man studies from 2002 through 2012
      Ignacio Garrido-Laguna, Danielle Tometich, Nan Hu, Jian Ying, Katherine Geiersbach, Jonathan Whisenant, Kai Wang, Jeffrey S. Ross, Sunil Sharma
      Oncoscience.2015; 2(3): 285.     CrossRef

    • PubReader PubReader
    • ePub LinkePub Link
    • Cite
      CITE
      export Copy Download
      Close
      Download Citation
      Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

      Format:
      • RIS — For EndNote, ProCite, RefWorks, and most other reference management software
      • BibTeX — For JabRef, BibDesk, and other BibTeX-specific software
      Include:
      • Citation for the content below
      Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2014
      Cancer Res Treat. 2017;49(2):292-305.   Published online March 9, 2017
      Close
    • XML DownloadXML Download
    Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2014
    Image Image Image Image Image Image
    Fig. 1. Annual age-standardized cancer incidence and death rates by sex for all sites from 1983 to 2014 in Korea. Age standardization was based on the Segi’s world standard population.
    Fig. 2. Trends in age-standardized incidences of selected cancers by sex from 1999 to 2014 in Korea. (A) Men. (B) Women. Age standardization was based on the Segi’s world standard population.
    Fig. 3. Annual age-standardized cancer mortalities of selected cancers by sex from 1983 to 2014 in Korea. (A) Men. (B) Women. Age standardization was based on the Segi’s world standard population.
    Fig. 4. Age-specific incidence rates of common cancers for 2014 in Korea. (A) Men. (B) Women
    Fig. 5. Trends in relative survival by year of diagnosis from 1999 to 2014. (A) All sites for both sexes. (B) All sites except thyroid cancer for both sexes.
    Fig. 6. Prevalence of common cancer sites by time period after cancer diagnosis. Prevalent cases were defined as the number of cancer patients alive on January 1, 2015 among all cancer patients diagnosed between 1999 and 2014.
    Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2014
    Site/Type New cases
    Deaths
    Prevalent casesa)
    Both sexes Men Women Both sexes Men Women Both sexes Men Women
    All sites 217,057 112,882 104,175 76,611 47,869 28,742 1,464,935 645,332 819,603
    Lip, oral cavity, and pharynx 3,191 2,261 930 1,097 824 273 19,687 13,253 6,434
    Esophagus 2,344 2,131 213 1,540 1,407 133 8,496 7,666 830
    Stomach 29,854 20,087 9,767 8,917 5,767 3,150 235,172 156,264 78,908
    Colon and rectum 26,978 16,182 10,796 8,338 4,760 3,578 202,295 121,057 81,238
    Liver 16,178 12,058 4,120 11,566 8,616 2,950 57,691 43,192 14,499
    Gallbladderb) 5,576 2,838 2,738 3,931 1,966 1,965 17,061 8,749 8,312
    Pancreas 5,948 3,191 2,757 5,116 2,752 2,364 8,472 4,539 3,933
    Larynx 1,111 1,048 63 410 371 39 9,262 8,714 548
    Lung 24,027 16,750 7,277 17,440 12,785 4,655 63,460 40,098 23,362
    Breast 18,381 77 18,304 2,271 17 2,254 158,916 622 158,294
    Cervix uteri 3,500 - 3,500 960 - 960 45,189 - 45,189
    Corpus uteri 2,214 - 2,214 264 - 264 18,381 - 18,381
    Ovary 2,413 - 2,413 1,021 - 1,021 16,161 - 16,161
    Prostate 9,785 9,785 - 1,667 1,667 - 62,256 62,256 -
    Testis 259 259 - 14 14 - 2,570 2,570 -
    Kidney 4,471 3,108 1,363 944 665 279 31,610 21,404 10,206
    Bladder 3,949 3,182 767 1,354 1,016 338 28,559 23,293 5,266
    Brain and CNS 1,725 917 808 1,285 716 569 9,500 4,898 4,602
    Thyroid 30,806 6,174 24,632 346 84 262 328,072 54,696 273,376
    Hodgkin lymphoma 278 167 111 70 38 32 2,318 1,471 847
    Non-Hodgkin lymphoma 4,948 2,766 2,182 1,574 910 664 31,553 16,984 14,569
    Multiple myeloma 1,396 758 638 864 473 391 4,811 2,513 2,298
    Leukemia 3,080 1,771 1,309 1,671 921 750 17,151 9,534 7,617
    Other and ill-defined 14,645 7,372 7,273 3,951 2,100 1,851 86,292 41,559 44,733
    Site/Type Crude incidence rate per 100,000
    Age-standardized incidence rate per 100,000a)
    Both sexes Men Women Both sexes Men Women
    All sites 427.6 444.9 410.3 270.7 302.2 255.5
    Lip, oral cavity, and pharynx 6.3 8.9 3.7 4.0 6.1 2.3
    Esophagus 4.6 8.4 0.8 2.8 5.5 0.4
    Stomach 58.8 79.2 38.5 35.8 52.7 21.4
    Colon and rectum 53.1 63.8 42.5 31.9 42.6 23.0
    Liver 31.9 47.5 16.2 19.4 31.4 8.6
    Gallbladderb) 11.0 11.2 10.8 6.2 7.4 5.2
    Pancreas 11.7 12.6 10.9 6.7 8.4 5.4
    Larynx 2.2 4.1 0.2 1.3 2.7 0.1
    Lung 47.3 66.0 28.7 27.2 43.7 14.9
    Breast 36.2 0.3 72.1 24.0 0.2 47.7
    Cervix uteri 6.9 - 13.8 4.6 - 9.0
    Corpus uteri 4.4 - 8.7 2.9 - 5.7
    Ovary 4.8 - 9.5 3.3 - 6.4
    Prostate 19.3 38.6 - 11.2 25.6 -
    Testis 0.5 1.0 - 0.5 1.0 -
    Kidney 8.8 12.2 5.4 5.7 8.4 3.3
    Bladder 7.8 12.5 3.0 4.5 8.4 1.5
    Brain and CNS 3.4 3.6 3.2 2.7 3.0 2.4
    Thyroid 60.7 24.3 97.0 43.3 17.3 69.8
    Hodgkin lymphoma 0.5 0.7 0.4 0.5 0.5 0.4
    Non-Hodgkin lymphoma 9.7 10.9 8.6 6.8 8.1 5.7
    Multiple myeloma 2.8 3.0 2.5 1.6 2.0 1.3
    Leukemia 6.1 7.0 5.2 5.2 6.1 4.3
    Other and ill-defined 28.8 29.1 28.6 18.6 21.0 16.6
    Rank Cause of death No. of deaths Percentage of all deaths Age-standardized death rate per 100,000a)
    All causes 267,692 100.0 295.7
    1 Cancer 76,611 28.6 85.1
    2 Heart disease 26,588 9.9 27.7
    3 Cerebrovascular disease 24,486 9.1 24.8
    4 Intentional self-harm (suicide) 13,836 5.2 19.3
    5 Pneumonia 12,021 4.5 11.6
    6 Diabetes mellitus 10,526 3.9 10.7
    7 Chronic lower respiratory diseases 7,171 2.7 6.9
    8 Disease of liver 6,635 2.5 8.0
    9 Transport accidents 5,700 2.1 8.0
    10 Hypertensive diseases 5,061 1.9 4.9
    Others 79,057 29.5 88.8
    Site/Type Crude mortality rate per 100,000
    Age-standardized mortality rate per 100,000a)
    Both sexes Men Women Both sexes Men Women
    All sites 150.9 188.7 113.2 85.1 125.8 55.6
    Lip, oral cavity, and pharynx 2.2 3.2 1.1 1.3 2.1 0.5
    Esophagus 3.0 5.5 0.5 1.7 3.6 0.2
    Stomach 17.6 22.7 12.4 9.7 15.1 5.7
    Colon and rectum 16.4 18.8 14.1 9.0 12.6 6.3
    Liver 22.8 34.0 11.6 13.4 22.4 5.6
    Gallbladderb) 7.7 7.7 7.7 4.1 5.1 3.4
    Pancreas 10.1 10.8 9.3 5.6 7.1 4.4
    Larynx 0.8 1.5 0.2 0.4 1.0 0.1
    Lung 34.4 50.4 18.3 18.8 33.2 8.5
    Breast 4.5 0.1 8.9 2.8 0.0 5.4
    Cervix uteri 1.9 - 3.8 1.1 - 2.1
    Corpus uteri 0.5 - 1.0 0.3 - 0.6
    Ovary 2.0 - 4.0 1.2 - 2.3
    Prostate 3.3 6.6 - 1.6 4.5 -
    Testis 0.0 0.1 - 0.0 0.0 -
    Kidney 1.9 2.6 1.1 1.0 1.8 0.5
    Bladder 2.7 4.0 1.3 1.4 2.7 0.5
    Brain and CNS 2.5 2.8 2.2 1.7 2.1 1.4
    Thyroid 0.7 0.3 1.0 0.4 0.2 0.4
    Hodgkin lymphoma 0.1 0.1 0.1 0.1 0.1 0.1
    Non-Hodgkin lymphoma 3.1 3.6 2.6 1.8 2.4 1.3
    Multiple myeloma 1.7 1.9 1.5 1.0 1.2 0.8
    Leukemia 3.3 3.6 3.0 2.2 2.7 1.8
    Other and ill-defined 7.8 8.3 7.3 4.5 5.8 3.6
    Site/Type Both sexes
    Men
    Women
    1999 2014 Trend 1
    Trend 2
    1999 2014 Trend 1
    Trend 2
    1999 2014 Trend 1
    Trend 2
    Year APC Year APC Year APC Year APC Year APC Year APC
    All sites 210.5 270.7 1999-2012 3.4a) 2012-2014 –6.6a) 285.0 302.2 1999-2011 1.7a) 2011-2014 –3.6a) 161.1 255.5 1999-2012 5.5a) 2012-2014 –7.9a)
    Lip, oral cavity, and pharynx 3.6 4.0 1999-2014 0.5 - - 6.1 6.1 1999-2014 –0.3 - - 1.6 2.3 1999-2014 1.3a) - -
    Esophagus 4.1 2.8 1999-2014 –2.2a) - - 8.8 5.5 1999-2014 –2.7a) - - 0.6 0.4 1999-2014 –2.0a) - -
    Stomach 43.6 35.8 1999-2011 –0.1 2011-2014 –5.8a) 66.2 52.7 1999-2011 –0.3a) 2011-2014 –6.3a) 26.7 21.4 1999-2011 –0.3 2011-2014 –5.4a)
    Colon and rectum 20.4 31.9 1999-2010 6.0a) 2010-2014 –4.6a) 26.2 42.6 1999-2010 6.5a) 2010-2014 –5.1a) 16.4 23.0 1999-2009 5.3a) 2009-2014 –2.5a)
    Liver 27.9 19.4 1999-2011 –1.7a) 2011-2014 –5.2a) 46.8 31.4 1999-2009 –1.8a) 2009-2014 –3.8a) 12.3 8.6 1999-2011 –1.4a) 2011-2014 –6.1a)
    Gallbladderb) 6.5 6.2 1999-2005 1.1 2005-2014 –1.2a) 8.1 7.4 1999-2014 –0.6a) - - 5.3 5.2 1999-2003 2.7 2003-2014 –1.2a)
    Pancreas 5.6 6.7 1999-2014 1.4a) - - 7.8 8.4 1999-2014 0.7a) - - 4.0 5.4 1999-2014 2.1a) - -
    Larynx 2.3 1.3 1999-2014 –3.6a) - - 4.9 2.7 1999-2014 –3.8a) - - 0.4 0.1 1999-2014 –7.1a) - -
    Lung 28.5 27.2 1999-2011 0.1 2011-2014 –1.7a) 51.4 43.7 1999-2005 –0.1 2005-2014 –1.5a) 12.4 14.9 1999-2011 1.9a) 2011-2014 –0.4
    Breast 10.7 24.0 1999-2005 7.6a) 2005-2014 4.5a) 0.2 0.2 1999-2014 –1.2 - - 20.9 47.7 1999-2007 7.0a) 2007-2014 4.2a)
    Cervix uteri 8.5 4.6 1999-2014 –4.1a) - - - - - - - - 16.3 9.0 1999-2014 –3.9a) - -
    Corpus uteri 1.4 2.9 1999-2009 6.2a) 2009-2014 3.0a) - - - - - - 2.8 5.7 1999-2009 6.4a) 2009-2014 3.1a)
    Ovary 2.7 3.3 1999-2014 1.5a) - - - - - - - - 5.0 6.4 1999-2014 1.8a) - -
    Prostate 3.1 11.2 1999-2009 15.1a) 2009-2014 0.6 8.4 25.6 1999-2009 13.6a) 2009-2014 –0.2 - - - - - -
    Testis 0.3 0.5 1999-2014 4.8a) - - 0.6 1.0 1999-2014 4.7a) - - - - - - - -
    Kidney 3.0 5.7 1999-2009 6.6a) 2009-2014 1.6a) 4.5 8.4 1999-2010 6.0a) 2010-2014 0.7 1.7 3.3 1999-2009 6.6a) 2009-2014 0.9
    Bladder 4.6 4.5 1999-2004 2.4a) 2004-2014 –1.5a) 9.0 8.4 1999-2005 1.5a) 2005-2014 –1.9a) 1.6 1.5 1999-2003 2.9 2003-2014 –2.0a)
    Brain and CNS 2.9 2.7 1999-2009 1.1a) 2009-2014 –2.4 3.2 3.0 1999-2009 1.3a) 2009-2014 –2.5 2.6 2.4 1999-2007 1.5a) 2007-2014 –1.7
    Thyroid 6.3 43.3 1999-2011 22.4a) 2011-2014 –10.8a) 2.1 17.3 1999-2012 22.8a) 2012-2014 –16.7a) 10.4 69.8 1999-2011 22.1a) 2011-2014 –11.9a)
    Hodgkin lymphoma 0.2 0.5 1999-2014 4.4a) - - 0.4 0.5 1999-2014 3.5a) - - 0.1 0.4 1999-2014 5.5a) - -
    Non-Hodgkin lymphoma 4.5 6.8 1999-2014 3.4a) - - 5.8 8.1 1999-2014 2.7a) - - 3.4 5.7 1999-2011 4.7a) 2011-2014 1.0
    Multiple myeloma 1.0 1.6 1999-2014 3.5a) - - 1.2 2.0 1999-2014 3.2a) - - 0.8 1.3 1999-2014 3.7a) - -
    Leukemia 4.7 5.2 1999-2014 0.9a) - - 5.5 6.1 1999-2014 0.9a) - - 3.9 4.3 1999-2014 0.6a) - -
    Other and ill-defined 14.3 18.6 1999-2014 2.2a) - - 17.9 21.0 1999-2014 1.6a) - - 11.8 16.6 1999-2010 3.2a) 2010-2014 0.7
    Site/Type Both sexes
    Men
    Women
    1999 2014 Trend 1
    Trend 2
    1999 2014 Trend 1
    Trend 2
    1999 2014 Trend 1
    Trend 2
    Year APC Year APC Year APC Year APC Year APC Year APC
    All sites 114.3 85.1 1999-2002 1.0 2002-2014 –2.7a) 176.6 125.8 1999-2002 1.1 2002-2014 –3.1a) 70.6 55.6 1999-2002 1.0 2002-2014 –2.2a)
    Lip, oral cavity, and pharynx 1.1 1.3 1999-2014 –2.0a) - - 2.0 2.1 1999-2014 –2.2a) - - 0.4 0.5 1999-2014 –3.1a) - -
    Esophagus 3.1 1.7 1999-2014 –4.5a) - - 6.8 3.6 1999-2014 –4.7a) - - 0.5 0.2 1999-2014 –5.2a) - -
    Stomach 23.8 9.7 1999-2003 –3.3a) 2003-2014 –6.6a) 36.9 15.1 1999-2002 –1.3 2002-2014 –6.7a) 14.6 5.7 1999-2003 –4.4a) 2003-2014 –6.6a)
    Colon and rectum 7.7 9.0 1999-2004 5.2a) 2004-2014 –1.0a) 10.5 12.6 1999-2004 5.6a) 2004-2014 –0.7a) 6.0 6.3 1999-2004 4.7a) 2004-2014 –1.7a)
    Liver 20.4 13.4 1999-2002 0.7 2002-2014 –3.6a) 35.3 22.4 1999-2002 –0.2 2002-2014 –3.7a) 8.3 5.6 1999-2002 2.9a) 2002-2014 –3.7a)
    Gallbladderb) 5.2 4.1 1999-2001 7.7 2001-2014 –2.8a) 6.8 5.1 1999-2001 6.7 2001-2014 –3.0a) 4.1 3.4 1999-2001 9.3 2001-2014 –2.7a)
    Pancreas 5.4 5.6 1999-2014 0.3a) - - 7.6 7.1 1999-2014 –0.4a) - - 3.9 4.4 1999-2014 0.8a) - -
    Larynx 1.6 0.4 1999-2014 –9.6a) - - 3.4 1.0 1999-2014 –9.1a) - - 0.4 0.1 1999-2012 –15.3a) 2012-2014 16.4
    Lung 22.4 18.8 1999-2001 3.7a) 2001-2014 –1.9a) 41.5 33.2 1999-2001 4.0 2001-2014 –2.4a) 9.4 8.5 1999-2001 4.2 2001-2014 –1.4a)
    Breast 2.2 2.8 1999-2014 1.4a) - - 0.1 0.0 1999-2014 –4.6a) - - 4.2 5.4 1999-2014 1.7a) - -
    Cervix uteri 1.4 1.1 1999-2003 8.8a) 2003-2014 –5.5a) - - - - - - 2.6 2.1 1999-2003 8.2a) 2003-2014 –5.2a)
    Corpus uteri 0.1 0.3 1999-2003 35.7a) 2003-2014 2.4a) - - - - - - 0.1 0.6 1999-2003 35.7a) 2003-2014 2.8a)
    Ovary 0.9 1.2 1999-2001 10.6 2001-2014 0.3 - - - - - - 1.7 2.3 1999-2014 1.1a) - -
    Prostate 0.9 1.6 1999-2002 16.1a) 2002-2014 1.2a) 2.6 4.5 1999-2002 16.7a) 2002-2014 0.7a) - - - - - -
    Testis 0.0 0.0 1999-2014 –2.3 - - 0.1 0.0 1999-2014 –2.5 - - - - - - - -
    Kidney 1.1 1.0 1999-2014 0.0 - - 1.8 1.8 1999-2014 0.2 - - 0.5 0.5 1999-2014 –0.8 - -
    Bladder 1.3 1.4 1999-2014 –1.2a) - - 2.6 2.7 1999-2014 –1.4a) - - 0.5 0.5 1999-2001 11.1 2001-2014 –2.0a)
    Brain and CNS 1.9 1.7 1999-2002 4.6 2002-2014 –2.1a) 2.2 2.1 1999-2014 –1.5a) - - 1.6 1.4 1999-2014 –1.5a) - -
    Thyroid 0.4 0.4 1999-2003 6.7 2003-2014 –3.9a) 0.3 0.2 1999-2002 15.4 2002-2014 –3.7a) 0.5 0.4 1999-2004 4.1 2004-2014 –4.5a)
    Hodgkin lymphoma 0.0 0.1 1999-2003 27.8a) 2003-2014 0.8 0.0 0.1 1999-2004 18.2a) 2004-2014 –1.2a) 0.0 0.1 1999-2002 56.3 2002-2014 3.5a)
    Non-Hodgkin lymphoma 2.1 1.8 1999-2014 –0.9a) - - 3.0 2.4 1999-2014 –1.2 - - 1.4 1.3 1999-2014 –0.5 - -
    Multiple myeloma 0.6 1.0 1999-2003 12.6a) 2003-2014 1.0 0.8 1.2 1999-2002 14.3a) 2002-2014 1.4a) 0.4 0.8 1999-2007 7.6a) 2007-2014 –1.6
    Leukemia 2.9 2.2 1999-2001 1.4 2001-2014 –2.0a) 3.5 2.7 1999-2014 –1.7a) - - 2.4 1.8 1999-2014 –2.0a) - -
    Other and ill-defined 7.8 4.5 1999-2014 –3.0a) - - 9.0 5.8 1999-2009 –0.5 2009-2014 –7.2a) 7.0 3.6 1999-2005 –7.1a) 2005-2014 –1.9a)
    Rank Age (yr)
    0-14 15-34 35-64 ≥ 65
    Men
     1 Leukemia (4.4) Thyroid (13.5) Stomach (86.7) Lung (445.7)
     2 Non-Hodgkin lymphoma (2.8) Non-Hodgkin lymphoma (3.2) Colon and rectum (66.0) Stomach (373.6)
     3 Brain and CNS (1.8) Colon and rectum (3.1) Liver (59.1) Colon and rectum (313.5)
     4 Liver (0.4) Leukemia (3.1) Lung (42.8) Prostate (284.2)
     5 Testis (0.3) Testis (2.1) Thyroid (38.8) Liver (192.4)
    Women
     1 Leukemia (4.1) Thyroid (54.7) Thyroid (161.4) Colon and rectum (168.5)
     2 Non-Hodgkin lymphoma (2.0) Breast (11.4) Breast (129.0) Stomach (142.2)
     3 Brain and CNS (1.7) Cervix uteri (5.3) Colon and rectum (38.7) Lung (126.8)
     4 Ovary (0.8) Ovary (3.3) Stomach (37.6) Breast (73.5)
     5 Thyroid (0.6) Stomach (3.3) Lung (22.2) Liver (71.7)
    Site/Type Both sexes
    Men
    Women
    1993-1995 1996-2000 2001-2005 2010-2014 Changea) 1993-1995 1996-2000 2001-2005 2010-2014 Changea) 1993-1995 1996-2000 2001-2005 2010-2014 Changea)
    All sites 41.2 44.0 53.9 70.3 29.1 31.7 35.3 45.3 62.2 30.5 53.4 55.3 64.0 78.2 24.8
    Lip, oral cavity, and pharynx 41.1 46.7 54.2 63.5 22.4 35.8 41.1 49.4 59.8 24.0 58.1 63.8 67.8 72.4 14.3
    Esophagus 12.7 15.2 21.2 35.0 22.3 11.8 14.3 20.5 34.7 22.9 23.7 24.2 29.6 37.3 13.6
    Stomach 42.8 46.6 57.7 74.4 31.6 43.0 46.9 58.4 75.3 32.3 42.6 46.0 56.4 72.7 30.1
    Colon and rectum 54.8 58.0 66.6 76.3 21.5 55.3 59.0 68.5 78.1 22.8 54.2 56.8 64.2 73.4 19.2
    Liver 10.7 13.2 20.2 32.8 22.1 9.9 12.9 20.2 33.1 23.2 13.6 14.2 20.5 31.9 18.3
    Gallbladderb) 17.3 19.7 22.8 29.2 11.9 16.6 20.3 23.4 30.1 13.5 18.0 19.1 22.4 28.4 10.4
    Pancreas 9.4 7.6 8.2 10.1 0.7 8.8 7.3 8.2 9.8 1.0 10.1 8.1 8.2 10.5 0.4
    Larynx 59.7 62.3 66.2 74.6 14.9 60.2 62.8 66.8 74.9 14.7 55.4 57.8 58.2 70.7 15.3
    Lung 11.3 12.7 16.2 25.1 13.8 10.4 11.6 15.0 21.9 11.5 14.2 16.2 19.7 32.4 18.2
    Breast 77.9 83.2 88.5 92.0 14.1 75.1 85.6 87.1 86.8 11.7 78.0 83.2 88.5 92.0 14.0
    Cervix uteri 77.5 80.0 81.3 79.7 2.2 - - - - - 77.5 80.0 81.3 79.7 2.2
    Corpus uteri 81.5 81.8 84.6 87.9 6.4 - - - - - 81.5 81.8 84.6 87.9 6.4
    Ovary 58.7 58.9 61.5 64.1 5.4 - - - - - 58.7 58.9 61.5 64.1 5.4
    Prostate 55.9 67.2 80.3 93.3 37.4 55.9 67.2 80.3 93.3 37.4 - - - - -
    Testis 85.4 90.4 90.6 96.0 10.6 85.4 90.4 90.6 96.0 10.6 - - - - -
    Kidney 62.0 66.1 73.4 81.3 19.3 60.8 64.4 72.8 80.8 20.0 64.5 69.7 74.5 82.5 18.0
    Bladder 69.1 73.1 75.6 75.6 6.5 70.0 74.8 77.4 77.5 7.5 65.5 66.3 68.6 67.9 2.4
    Brain and CNS 38.5 39.0 40.8 40.8 2.3 37.2 37.5 40.2 39.4 2.2 40.2 40.7 41.5 42.4 2.2
    Thyroid 94.2 94.9 98.3 100.2 6.0 87.2 89.5 95.8 100.5 13.3 95.4 95.9 98.7 100.1 4.7
    Hodgkin lymphoma 68.0 71.2 76.7 80.6 12.6 67.6 68.1 74.7 81.6 14.0 68.6 77.4 80.7 78.8 10.2
    Non-Hodgkin lymphoma 46.6 50.8 59.9 69.1 22.5 45.3 48.9 58.1 67.4 22.1 48.7 53.5 62.4 71.1 22.4
    Multiple myeloma 22.1 19.8 29.3 40.1 18.0 21.1 17.8 29.6 39.7 18.6 23.3 22.1 29.1 40.6 17.3
    Leukemia 26.5 33.3 41.8 51.1 24.6 26.2 32.3 41.7 50.9 24.7 26.8 34.6 42.0 51.4 24.6
    Other and ill-defined 42.1 45.9 56.0 69.1 27.0 37.4 42.4 52.3 65.7 28.3 47.4 50.0 60.0 72.6 25.2
    Site/Type Crude prevalence rate per 100,000a)
    Age-standardized prevalence rate per 100,000b)
    Both sexes Men Women Both sexes Men Women
    All sites 2,885.8 2,543.2 3,228.2 1,837.6 1,730.9 2,027.1
    Lip, oral cavity, and pharynx 38.8 52.2 25.3 25.0 35.5 15.8
    Esophagus 16.7 30.2 3.3 9.9 20.0 1.7
    Stomach 463.3 615.8 310.8 278.1 407.6 171.5
    Colon and rectum 398.5 477.1 320.0 237.5 317.6 173.1
    Liver 113.6 170.2 57.1 71.8 114.2 33.5
    Gallbladderc) 33.6 34.5 32.7 19.4 22.8 16.8
    Pancreas 16.7 17.9 15.5 10.2 12.1 8.7
    Larynx 18.2 34.3 2.2 10.8 22.8 1.1
    Lung 125.0 158.0 92.0 74.5 105.0 51.0
    Breast 313.1 2.5 623.5 201.8 1.6 396.8
    Cervix uteri 89.0 - 178.0 56.7 - 110.5
    Corpus uteri 36.2 - 72.4 23.7 - 46.5
    Ovary 31.8 - 63.7 22.2 - 44.0
    Prostate 122.6 245.3 - 67.1 160.7 -
    Testis 5.1 10.1 - 4.6 9.0 -
    Kidney 62.3 84.4 40.2 40.2 57.5 24.9
    Bladder 56.3 91.8 20.7 32.1 61.2 10.1
    Brain and CNS 18.7 19.3 18.1 16.1 17.0 15.0
    Thyroid 646.3 215.6 1076.8 438.4 148.2 726.7
    Hodgkin lymphoma 4.6 5.8 3.3 3.8 4.8 2.9
    Non-Hodgkin lymphoma 62.2 66.9 57.4 44.1 50.1 38.7
    Multiple myeloma 9.5 9.9 9.1 5.8 6.6 5.1
    Leukemia 33.8 37.6 30.0 31.7 35.6 28.0
    Other and ill-defined 170.0 163.8 176.2 112.0 120.7 104.7
    Table 1. Cancer incidence, deaths, and prevalence by sex in Korea, 2014

    CNS, central nervous system.

    Limited-duration prevalent cases on January 1, 2015. These are patients who were diagnosed between January 1, 1999 and December 31, 2014 and who were alive on January 1, 2015. Multiple primary cancer cases were counted multiple times,

    Includes the gallbladder and other/unspecified parts of the biliary tract.

    Table 2. Crude and age-standardized cancer incidence rates by sex in Korea, 2014

    CNS, central nervous system.

    Age-adjusted using the Segi’s world standard population,

    Includes the gallbladder and other/unspecified parts of the biliary tract.

    Table 3. The top 10 leading causes of death in Korea, 2014

    Source: Mortality Data, 2014, Statistics Korea [8].

    Age-adjusted using the Segi’s world standard population.

    Table 4. Crude and age-standardized cancer mortality rates by sex in Korea, 2014

    CNS, central nervous system.

    Age-adjusted using the world standard population,

    Includes the gallbladder and other/unspecified parts of the biliary tract.

    Table 5. Trends in cancer incidence rates from 1999 to 2014 in Korea

    APC was calculated using age-standardized incidence data based on the Segi’s world standard population. APC, annual percentage change; CNS, central nervous system.

    Significantly different from zero (p < 0.05),

    Includes the gallbladder and other/unspecified parts of the biliary tract.

    Table 6. Trends in cancer mortality rates from 1999 to 2014 in Korea

    APC was calculated using age-standardized incidence data based on the Segi’s world standard population. APC, annual percentage change; CNS, central nervous system.

    Significantly different from zero (p < 0.05),

    Includes the gallbladder and other/unspecified parts of the biliary tract.

    Table 7. The five common sites of cancer incidence by age group and sex in Korea, 2014

    CNS, central nervous system.

    Table 8. Trends in the 5-year relative survival rates (%) by year of diagnosis from 1993 to 2014 in Korea

    CNS, central nervous system.

    Percentage change in 5-year relative survival from 1993 to 1995 and 2010 to 2014,

    Includes the gallbladder and other/unspecified parts of the biliary tract.

    Table 9. Crude and age-standardized rates of cancer prevalence by sex on January 1, 2015 in Korea

    CNS, central nervous system.

    Crude prevalence rate: number of prevalent cases divided by the corresponding person-years of observation. Prevalent cases were defined as patients who were diagnosed between January 1, 1999 and December 31, 2014 and who were alive on January 1, 2015. Multiple primary cancer cases were counted multiple times,

    Age-adjusted using the Segi’s world standard population,

    Includes the gallbladder and other/unspecified parts of the biliary tract.


    Cancer Res Treat : Cancer Research and Treatment
    Close layer
    TOP